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and without Hospice Services
Abstract
Aims
Aims: We sought to identify differences in pain management between two groups; nursing home
residents with malignant cancer and dementia with and without hospice services.
Methods
Methods: Decedent records from 2003-2009 were assessed for diagnosis of dementia and cause of
death as cancer. Ten malignant cancer diagnoses were determined a priori from the CDC 2004 data on
the top 10 malignant cancers for all races and genders. Fifty-five decedents from 10 nursing homes were
included in the final sample. Four instruments were used: Minimum Data Set (MDS) a standardized
assessment tool required of most U.S. nursing homes. A large comprehensive assessment is conducted
yearly followed by smaller quarterly assessments. The MDS collects demographic and diagnostic
variables, as well as clinical, functional, psychosocial, and cognitive assessments. Cognitive Performance
Scale (CPS scored from 1 borderline-intact to 6 very severe impairment); Discomfort Behavior Scale (DBS
scored from 0 no discomfort behavior identified to 102 maximum identifiable discomfort behavior); and
Equivalent Dose Units (EDU’s) of opioid analgesic calculated and totaled over the last 2 weeks of life. We
calculated the CPS score from the admission MDS because we believed cognitive levels were unlikely to
improve over time. DBS scores were calculated from the last MDS prior to death in an effort to capture
active cancer pain at the end-of-life. We realized the last MDS assessment might have been in the
previous 90 days. The study received exempt status from the office of human protection.
Results
Results: Total EDU’s were significantly greater among hospice enrollees (U 226.5, p <.05). There is a
significantly greater likelihood of being prescribed a scheduled narcotic analgesic (OR 5.5; 95% CI
1.8-18.8) and a PRN narcotic analgesic (OR 3.6; 95% CI 1.2-11.3) when enrolled in hospice. Nursing home
residents not enrolled in hospice had a significantly (U 195.0, p < .01) lower CPS scores than those
enrolled in hospice. Decedents with lower cognitive levels were more likely (OR 4.9; 95% CI 1.6-15.6) to
have a DBS score of zero. Forty percent of decedents with metastatic cancer and dementia received no
opioid during the last 2 weeks of life.
Conclusions
Conclusions: We have demonstrated that pain among nursing home residents with dementia and cancer
is a serious problem. Forty percent of our decedents received no opioid at the end of life. None (n = 12) of
the subjects identified in the lowest CPS score (6) category were enrolled in hospice. One reason appears
to be blunted pain related behaviors. Among the severely cognitively impaired whose pain behaviors
become blunted, scheduled pain medications may be the best way to manage their pain. Pain behavioral
tools are better suited for individuals with mild and moderate cognitive impairment but become less
reliable in the severely cognitively impaired. New methods for assessing pain in this highly vulnerable
population are needed.
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ABSTRACT
Aims: We sought to identify differences in pain management between two groups:
nursing home residents with malignant cancer and dementia with and without hospice
services.
Methods: Decedent records from 2003-2009 were assessed for diagnosis of
dementia and cause of death as cancer. Ten malignant cancer diagnoses were determined
a priori from the CDC 2004 data on the top 10 malignant cancers for all races and
genders. Fifty-five decedents from 10 nursing homes were included in the final sample.
Four instruments were used: Minimum Data Set (MDS) a standardized assessment tool
required of most U.S. nursing homes. A large comprehensive assessment is conducted
yearly followed by smaller quarterly assessments. The MDS collects demographic and
diagnostic variables, as well as clinical, functional, psychosocial, and cognitive
assessments. Cognitive Performance Scale (CPS scored from 1 borderline-intact to 6 very
severe impairment); Discomfort Behavior Scale (DBS scored from 0 no discomfort
behavior identified to 102 maximum identifiable discomfort behavior); and Equivalent
Dose Units (EDU’s) of opioid analgesic calculated and totaled over the last 2 weeks of
life. We calculated the CPS score from the admission MDS because we believed
cognitive levels were unlikely to improve over time. DBS scores were calculated from
the last MDS prior to death in an effort to capture active cancer pain at the end-of-life.
We realized the last MDS assessment might have been in the previous 90 days. The study
received exempt status from the office of human protection.
Results: Total EDU’s were significantly greater among hospice enrollees (U 226.5,
p <.05). There is a significantly greater likelihood of being prescribed a scheduled
narcotic analgesic (OR 5.5; 95% CI 1.8-18.8) and a PRN narcotic analgesic (OR 3.6;
95% CI 1.2-11.3) when enrolled in hospice. Nursing home residents not enrolled in
hospice had a significantly (U 195.0, p < .01) lower CPS scores than those enrolled in
hospice. Decedents with lower cognitive levels were more likely (OR 4.9; 95% CI 1.615.6) to have a DBS score of zero. Forty percent of decedents with metastatic cancer and
dementia received no opioid during the last 2 weeks of life.
Conclusions: We have demonstrated that pain among nursing home residents with
dementia and cancer is a serious problem. Forty percent of our decedents received no
opioid at the end of life. None (n = 12) of the subjects identified in the lowest CPS score
(6) category were enrolled in hospice. One reason appears to be blunted pain related
behaviors. Among the severely cognitively impaired whose pain behaviors become
blunted, scheduled pain medications may be the best way to manage their pain. Pain
behavioral tools are better suited for individuals with mild and moderate cognitive
impairment but become less reliable in the severely cognitively impaired. New methods
for assessing pain in this highly vulnerable population are needed.
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CHAPTER 1. INTRODUCTION
BACKGROUND
The nursing literature has long reported that nursing home residents do not
consistently receive high-quality palliative care (Hanson, Sengupta, & Slubicki, 2005),
and that such environments can be deficient in end-of-life treatment (Munn, Hanson,
Zimmerman, Sloane, & Mitchell, 2006; Reynolds, Henderson, Schulman, & Hanson,
2002). In particular, the management of pain at the end of life for nursing home residents
could be much improved (Buchanan, Choi, Wang, & Ju, 2004; Hoffman & Tarzain,
2005); many die from conditions that cause substantial physical distress. Such residents
would be well served by enrollment in hospice services, warranted when the patient has a
fatal illness and requires close attention to pain management. According to one study,
only a little more than a third (37.1%) of nursing home residents with dementia who had
a terminal diagnosis had daily pain or frequent pain suitable for hospice services
(Mitchell, Morris, Park, & Fries, 2004). In contrast, Munn et al. (2006) reported that
residents enrolled in hospice services were 22% more likely to receive pain treatment.
Currently 20% to 24% (Ersek & Wilson, 2003; Hanson, Reynolds, Henderson, &
Pickard, 2005) of all deaths in the U.S. occur in nursing homes, which means that each
year approximately 480,000 to 821,000 people expire in such facilities. Researchers
suggest that these percentages will double by the year 2040 (Ersek & Wilson, 2003). The
annual mortality rate in nursing homes varies from 24% to 32% (Dobbs, Hanson,
Zimmerman, Williams, & Munn, 2006), and first-year mortality rates hover around 34%
(Munn, et al., 2006). Investigators have found that nearly 50% of the nursing home
population has dementia (Magaziner, et al., 2000). Clearly, significant numbers of older
adults live and die in nursing homes. Increasing the quality of life at the end of life
among nursing home residents, especially those with dementia, is a challenge.
While a patient’s self-reports are the accepted standard in pain assessment,
nursing home residents with cognitive impairment (CI) are frequently unable to
understand and report pain, and thus such self-reports may be unreliable. This situation is
complicated by the presence of depression or dementia, which can directly affect
residents’ perceptions.
Nurses experienced in long-term care or family members may well be able to
offer assessments of a resident’s pain through proxy pain ratings (McCaffery, 1999), but
such accounts by individuals close to the resident often reflect their beliefs and emotional
reactions to the situation. Another challenge to the accurate assessment of pain is that the
typical signs associated with acute pain are not useful indicators in older adults, and
currently no biological markers exist to assess pain (Davis & Srivastava, 2003). Further,
without a subjective report of pain, there can be no pain intensity rating (Pasero &
McCaffery, 2005).
The use of hospice services to assist in the appropriate and effective management
of pain among nursing home residents with CI may facilitate a more dignified death.
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Hospice entails an interdisciplinary approach, addressing a patient’s physical, sociologic,
spiritual, and psychogenic symptoms. In one study, nursing home residents identified
indicators of such a death as the maintenance of social networks, not becoming a burden
to others, staying active, not being in pain, and respecting one’s wishes to pass on
(Pleschberger, 2007). Highly trained hospice staff offer a number of services, including
pain management at the end of life (Hoffman & Tarzain, 2005). Given a median survival
time of 4 months and a mean survival time of 6.3 months for nursing home residents with
severe dementia (Luchins, Hanrahan, & Murphy, 1997), hospice services seem
particularly appropriate for such patients (Cherney, 2008). Such services may offer the
nursing home staff and residents’ families support while simultaneously helping older
adults with severe CI manage pain and ease the transition from life to death.
PURPOSE
The purpose of this study was to identify the differences in pain medication
administration between two different groups of deceased subjects, nursing home residents
with malignant cancer and dementia with and without hospice services.
SPECIFIC AIMS
The aims that guided this study were derived from the literature and are described
next; associated hypotheses follow each study aim.
Specific Aim One
Specific Aim One was to determine the differences in administered pain
medications for cognitively impaired residents who died from cancer while receiving
hospice services as compared with those not receiving hospice services. The following
eight hypotheses were associated with this aim.


Hypothesis 1. Residents who received hospice services would receive more
scheduled narcotic analgesic than residents who did not receive hospice
services.



Hypothesis 2. Residents who received hospice services would receive greater
total equivalent dose units (EDU’s) of narcotic analgesic than residents who
did not receive hospice services.



Hypothesis 3. Residents who received hospice services would receive greater
total dose number of non-narcotic analgesics (TDNN) than residents who did
not receive hospice services.



Hypothesis 4. Residents who received hospice services would receive more
PRN narcotic analgesic than residents who did not receive hospice services.
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Hypothesis 5. Residents who received hospice services would receive more
scheduled non-narcotic analgesic than residents who did not receive hospice
services.



Hypothesis 6. Residents who received hospice services would receive more
PRN non-narcotic analgesic than residents who did not receive hospice
services.



Hypothesis 7. Residents who received hospice services would have different
cognitive performance scores (CPS) than residents who did not receive
hospice services.



Hypothesis 8. Residents who received hospice services would receive greater
total dose numbers of drug potentiators (TDNP) than would residents who did
not receive hospice services.

Specific Aim Two
Specific Aim two was to determine if discomfort related pain behaviors among
nursing home residents with cancer and dementia decrease with increasing cognitive
impairment. The following hypothesis is associated with this aim.
Hypothesis 9. Discomfort related pain behaviors among all residents will be
decreased with increasing cognitive impairment.
CONCEPTUAL FRAMEWORK
Hospice is an interdisciplinary healthcare practice with an emphasis on addressing
the terminally ill patient’s physical, sociologic, spiritual, and psychological symptoms.
Hospice is warranted when a nursing home resident has an irreversible, progressive
illness and is near the end of life. Hospice was founded on 10 basic principles
(Connecticut Hospice, 1998) (Figure 1-1) including: the family and patient are
considered the unit of care, an interdisciplinary team provides care, 24 hour availability
of professional assistance, with a primary goal of pain relief and management of
associated symptoms (Parham, 2002).
The hospice philosophy incorporates the biopsychosocial paradigm. Several
assumptions about the origin of pain are integrated into the biopsychosocial approach
(Davis & Srivastava, 2003; Gatchel, 2004; Killinger, Morley, Kettner, & Kauric, 2001).
In this model, biological, mental health, and socio-environmental variables combine to
create the pain experience and thus all require attention when treatment is planned.
This conceptual framework guided the research question that nursing home
residents with malignant cancer and dementia with hospice may have different pain
management than those who did not receive hospice services.
3

1. The patient and family are regarded as the unit of care.
2. Services are physician directed and nurse coordinated.
3. Emphasis is on control of symptoms (physical, sociologic, spiritual, and
psychogenic).
4. An interdisciplinary team provides care.
5. Trained volunteers are an integral part of the team.
6. Services are 24 hours a day, 7 days a week, on call, with emphasis on availability of
medical and nursing skills.
7. Family members receive bereavement follow-up.
8. Home care and inpatient care are coordinated.
9. Patients are accepted on the basis of health needs, not on ability to pay.
10. There are structured systems for staff support and communication
Figure 1-1. 10 Principles of Hospice Care
Source: Modified with permission from Connecticut Hospice (1998). 10 principles of
hospice care. Cancer Therapeutics, 1(2), 11.
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DEFINITIONS
The definitions that follow were used to conceptually guide and operationally
define various components of this research.


Cancer. Any one of 10 malignant ICD-9 cancer codes established a priori and
a confirmatory diagnosis of cancer in the medical record. These included colorectal, female breast, prostate, lung, uterine, melanoma of the skin, ovarian,
kidney, non-Hodgkin’s lymphoma, and bladder.



Dementia. For the purposes of this study dementia was defined as a diagnosis
of Alzheimer’s disease (Dementia of the Alzheimer’s Type or DAT), Lewy
body dementia, vascular dementia, or mixed as recorded in the medical
record.



Hospice. Enrollment in a Medicare approved hospice program as recorded in
the medical record.



Minimum Data Set (MDS). An assessment instrument required in all longterm care facilities that receive federal Medicare/Medicaid funds.



Discomfort. For the purposes of this retrospective study we define discomfort
behaviors as those behaviors that may indicate physical discomfort or pain.
Therefore the terms “discomfort” and “pain” in this study are used
interchangeably.
ASSUMPTIONS

This study involves a retrospective analysis of patient chart information, and as
such a major assumption is that these records will be accurate.
LIMITATIONS
As noted above, the author assumes that all data in the medical record were
accurate; therefore, the first major limitation is that some information may not be
accurate. The record may not reflect the actual care the resident the received. The nurse
who administered care to the resident may not have recorded the MDS data. A diagnosis
of malignant cancer does not necessarily mean the individual had active cancer upon
death, however every effort to ensure active cancer was made and if undeterminable, the
subject was not considered for this study. The nurse providing the care is most often an
LPN and the MDS must be signed by an RN who may or may not have completed the
form.
There were limitations in this retrospective study design. The convenience sample
was selected over six years with multiple providers coding the MDS data and charting
5

diagnoses and medication administration. The MDS has been identified with limitations
when used as a research tool (Mentes, Culp, Maas, & Rantz, 1999; Ryan, Stone, &
Raynor, 2004) and this potentially weakens the study findings.
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CHAPTER 2. REVIEW OF THE LITERATURE
COGNITIVE IMPAIRMENT
Defining Cognitive Impairment
Carr, Duchek, Meuser, and Morris (2006) define CI as a “decline in at least one of
the following areas: short-term memory, attention, orientation, judgment and problemsolving-skills, and visuospatial skills.” The Geriatric Research Group (n.d.) has defined
CI as “short-term memory loss and difficulty finding words.” Mild CI has been defined
as “cognitive deficits that fall short of the diagnostic criteria for dementia” (Carr, et al.,
2006, p. 1029). Additionally, mild CI has been defined as impairment without dementia
or functional impairment (Plassman, et al., 2008).
Measuring Cognitive Impairment
The Cognitive Performance Scale (CPS) (Morris, et al., 1994) was developed from
five MDS items and is reported both reliable and valid when an individual is trained on
its use (Paquay, et al., 2007). Wu and colleagues (2003) quantified the severity of
cognitive impairment with the CPS into three categories, no or mild CI (0-1), moderate
CI (2-3), and severe CI (4-6). They reported that scores of 4-6 have been reported to
correlate with a MMSE score of <10, indicating severe CI while CPS scores of 5 and 6
are equivalent to an MMSE of <5 (Hartmaier, et al., 1995; Morris, et al., 1994) indicating
very severe impairment.
Etiology and Pathophysiology
The presence of the apoliopoprotein E-4 (APOE-4) gene and cardiovascular risk
factors and hypertension have a direct association with dementia of the Alzheimer’s type
and vascular dementia Other genetic precursors have been identified, the APP and three
other APOE alleles (APOE e1, e2, and e3) and the presenilins (Beatty, 2006). All of the
APP genes lead to the production of A-beta 42, a neurotoxic amino acid sequence, which
has been implicated in the formation of amyloid plaques (Beatty, 2006). It is
hypothesized that amyloid plaques occur first in the pathology of dementia of the
Alzheimer’s type (Beatty, 2006).
Dementia of the Alzheimer’s Type (AD)
The pathopysiology of Alzheimer’s disease is not exactly known. Several theories
are being investigated, 1) loss of neurotransmitter stimulation by choline
acetyltransferase; 2) mutation for encoding amyloid precursor protein; 3) alterations in
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apoliopoprotein E, which binds beta amyloid; and 4) pathologic activation of N-methylD-asparate (NMDA) receptors resulting in an influx of excess calcium (Alzheimer's
Association, 2008).
Each of these theories is linked to the formation of insoluble amyloid plaques in
brain tissue and blood vessels. AD has also been linked to the breakdown of lysosomal
pathways. These pathways are the precursor protein to yield beta amyloid, a neurotoxic
substance coded by chromosome 21 (McCance & Huether, 2006). Another theory is that
once the plaques form, complement proteins attach to them, attracting microglia (the
brains immune force), which release toxins in an attempt to destroy the plaques creating
an endless cycle (Alzheimer's Association, 2008).
Additional destruction of brain tissue results when the stabilizing tau proteins
detach from microtubules and form insoluble helical filaments called neurofibrillary
tangles (McCance & Huether, 2006). Further damage occurs in cerebral arteries where
amyloid is deposited and groups of nerve cells degenerate around this deposited amyloid
core (Alzheimer’s Association, 2008). Microscopic examination reveals senile plaques,
which disrupt nerve impulse transmission (Alzheimer's Association, 2008). The greater
the number of senile plaques and tangles the more dysfunction associated with AD
(McCance & Huether, 2006).
Vascular Dementia
Multi-infarct dementia is a common form of dementia and is thought to be a
combination of: 1) vascular mild cognitive impairment, 2) multi-infarct dementia, 3)
vascular dementia due to a strategic single infarct (affecting the thalamus, the anterior
cerebral artery, the parietal lobes or the cingulate gyrus), 4) vascular dementia due to
hemorrhagic lesions, 5) small vessel disease (which includes vascular dementia due to
brain lesions and Binswanger's disease), and 6) mixed Alzheimer's and vascular dementia
(Alzheimer's Association, 2008; Alzheimer's Society, 2008).
Vascular lesions can be the result of diffuse cerebrovascular disease or focal
lesions (or a combination of both, which is what is observed in the majority of cases).
Mixed dementia is diagnosed when patients have evidence of AD and cerebrovascular
disease, either clinically or based on neuroimaging evidence of ischemic lesions
(Alzheimer's Association, 2008; Alzheimer's Society, 2008).
Lewey Body Dementia
Lewy Body Dementia (LBD) exhibits clinical overlap between Alzheimer's
disease and Parkinson's disease (McCance & Huether, 2006). Lewy bodies present as
round masses that displace other cell components (Alzheimer’s Association, 2008). There
are two types: classical (brain stem) Lewy bodies and cortical Lewy bodies. Conventional
Lewy bodies are eosinophilic cytoplasmic enclosures that consist of dense cores
surrounded by halos of 10-nm wide radiating fibrils (McCance & Huether, 2006), the
8

primary structural component of which is alpha-synuclein, whereas a cortical Lewy body
is less well-defined and lacks the halo (McCance & Huether, 2006). When Lewy body
inclusions are found in the cortex, they often co-occur with Alzheimer's disease including
neurofibrillary tangles (abnormal tau protein) and senile plaques (deposited beta-amyloid
protein) (Alzheimer's Association, 2008; Alzheimer's Society, 2008).
Within LBD, the loss of cholinergic (acetylcholine-producing) neurons is thought
to account for the degradation of cognitive and emotional functioning as in AD, while the
loss of dopamine-producing neurons is thought to account for the degradation of motor
control as in Parkinson's disease (McCance & Huether, 2006).
Differentiation between Dementia and Delirium
Nursing literature often uses the terms cognitive impairment, dementia, delirium,
and confusion. This study is concerned with nursing home residents with a diagnosis of
dementia, including Alzheimer’s disease. The American Psychiatric Association defined
dementia as the “loss of intellectual abilities (medically called cognitive function) of
sufficient severity to interfere with social or occupational functioning” (Maslow &
Mezey, 2008; World Health Organization, 2006). Intellectual abilities include memory
and learning, attention, concentration and orientation, thinking (e.g., problem solving,
abstraction), calculation, language (comprehension, word finding), and geographic
orientation. According to the World Health Organization (2006), “Dementia leads to a
loss in all [emphasis added] of these cognitive abilities . . . . Dementia is a loss of
multiple components of intellectual function . . . . Contrary to popular belief, loss of
memory is not the only deficit in dementia.” For Bjoro and Herr (Bjoro & Herr, 2008),
dementia involves the development of multiple cognitive losses, loss of language, ability
to recognize or identify objects, and executive function. In other words, dementia results
in a significant loss of intellectual abilities severe enough to interfere with social or
occupational functioning.
Dementia and delirium should be considered different diagnoses (Beatty, 2006), a
point summarized well by Herr and Garand (2001, p. 463) who define delirium as “acute
confusion” and dementia as “chronic confusion.” For Barrie (2002, p. 29), dementia is a
worsening of intellectual function leading to a decline in the ability to perform activities
of daily living and the most common cause (60%) of dementia is Alzheimer’s disease
often called senile dementia. The Geriatric Research Group (n.d.) offers another
definition: “[Dementia is] a common clinical syndrome characterized by decline in
cognitive function from previously attained intellectual level that is sustained for months
or years.” Other causes of dementia include vascular dementia 10%, and Pick’s disease,
Parkinson’s disease, and Cruetzfeldt-Jacob disease cause a small fraction of cases.
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PAIN AND DEMENTIA
Determining the Presence of Pain in Severe Dementia
Questions have arisen as to whether Alzheimer’s disease alters the processing of
pain by the brain. Individuals with DAT receive fewer analgesics and report less pain
than cognitively intact controls (Cook, Niven, & Downs, 1999; Farrell, Katz, & Helme,
1996; Frampton, 2003). However, it remains unclear if differences in analgesic intake or
self report result from impaired communication, impaired memory, or impaired
perception of pain resulting from alterations in pain transmission in the brain (Farrell, et
al., 1996; Scherder & Bouma, 1997; E. Scherder, et al., 2003; Scherder, et al., 2005).
Questions arise whether the lower level of pain medication is because of less pain or
because clinicians are not adequately managing pain in patients with severe DAT.
Evidence does not currently exist determining if the pathways in the brain of individuals
with severe DAT are intact (Cole, et al., 2006) and this question must be addressed in
order to establish evidenced based nursing care (Algase, 2006; Harvath, et al., 2006).
In 1990, functional mapping of the human brain using venous blood oxygenation
level-dependent (BOLD) magnetic resonance imaging contrast was developed (Ogawa &
Lee, 1990; Ogawa, Lee, Nayak, & Glynn, 1990). The BOLD contrast relies on changes in
deoxyhemoglobin levels in the blood as the endogenous magnetic contrast agent (Ogawa,
et al., 1990). This means that changes in deoxyhemoglobin levels in the brain cause
changes in the MRI signal leading to functional brain mapping or fMRI (Ogawa & Lee,
1990) and this mapping can describe acute pain in the brain (Davis, 2006).
Pain is a subjective experience with sensory-discriminative, affectivemotivational, and cognitive-evaluative components (Melzack & Casey, 1968). Each of
these components of pain is regulated by lateral and medial pain pathways in the brain.
The location, intensity, and quality of pain are modulated by the lateral pain system
consisting of the spinothalamic tract ascending from the ventro-posterior lateral thalamus
onto the primary and secondary cortices (Bornhovd, et al., 2002; Cole, et al., 2006). The
medial pathway, a second major pain pathway, branches at the medulla and ascends via
the medial thalamus to the hypothalamic nuclei, limbic regions (cingulate cortex), insula
cortex and then onto the prefrontal areas which are involved in the control of emotion,
arousal, and attention (Bornhovd, et al., 2002; Cole, et al., 2006; Craig, n.d.; Davis,
2006). The medial pathway is believed to mediate the unpleasant, affective dimension,
and the response to noxious stimulus (Bornhovd, et al., 2002; Price, 2000; Treede,
Kenshalo, Gracely, & Jones, 1999). Further evidence from fMRI (Thompson, Hayashi,
de Zubicaray, & Jones, 2003) and pathology (Rub, Del Tredici K, Del Turco, & Braak,
2002) suggests that the neurodegenerative changes in DAT affect the medial pain system
and yet the lateral pain tract is preserved (Scherder & Bouma, 1997, 2000).
These findings suggest that individuals with DAT have pain, but may not be able
to express it. Research among cognitively intact individuals using fMRI has been able to
discern between lateral and medial pain pathways demonstrating sensory and emotional
pain perception (Bingel, et al., 2002; Bornhovd, et al., 2002). This means that very
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severely cognitively impaired older adults (CIOA) may be able to feel the pain but be
unable to verbalize or express it through physical behaviors.
The prevalence of painful conditions increases in clinical settings (Hutt, Pepper,
Vojir, Fink, & Jones, 2006; Marzinski, 1991; Scherder, Bouma, Borkent, & Rahman,
1999) and administration of analgesic medication decrease as cognitive impairment
increases (Cook, et al., 1999; Frampton, 2003; Herr, Mobily, Kouhout, & Wagner, 1998;
Monroe, 2010; Scherder & Bouma, 2000). This decrease in medication occurs despite the
fact that the pain threshold does not differ between mild and moderately CIOA and the
intact (Cole, et al., 2006). Gibson and colleagues (2001) used EEG to show that peak
amplitude CNS activated evoked potentials are not diminished among verbally
communicative subjects with DAT. A limitation of EEG studies is that while cortical
processing of noxious stimulus is present, spatial resolution is not possible, limiting the
conclusions about how the disease may alter pain-related CNS processing (Cole, et al.,
2006). Cole and colleagues (2006) used fMRI to study the pain pathways among verbally
communicative individuals with mild to moderate DAT and found that both lateral and
medial pain pathways were preserved.
Current Theories Explaining Decreased Pain in Persons with Dementia
Farrell et al (1996) suggested that language and memory problems might
confound reports of pain. Scherder et al (2003) proposed that the neuropathology
associated with dementia changes the experience of pain through interruption of
neurological transmission. A second neuropathology theory is that the formation of toxic
mediators results in out of control inflammatory responses potentially inhibiting or
destroying transmissions (Mulugeta, et al., 2008). Damage to different areas of the brain
has been associated with both increases and decreases in pain intensity and effect
(Melzack & Wall, 1988) and different types of dementia may be associated with different
types of pain experience (Scherder, Sergeant, & Swaab, 2003). The theory of altered
autonomic nervous system response has been studied. Cognitively impaired individuals
showed blunted heart rate and blood pressure in response to noxious stimuli compared to
matched controls (Benedetti, et al., 1999; Rainero, Vighetti, Bergamasco, Pinessi, &
Benedetti, 2000). However, there were no differences between groups at more intense
levels of stimulation (Rainero, et al., 2000). Much of this work has been conducted on
acute pain and presently there is not sufficient empirical evidence to support any one
theory.
PAIN IN COGNITIVELY IMPAIRED NURSING HOME RESIDENTS
In 1979, Margo McCaffery (1999, p. 8) defined pain as “Whatever the
experiencing person says it is, existing where ever he says it does.” The International
Association for the Study of Pain provides one widely accepted definition of pain: “An
unpleasant sensory and emotional experience associated with actual or potential tissue
damage, or described in terms of such damage (International Association for the Study of
Pain, 1979). The subjective nature of pain is well characterized by (Johansson, Hamburg,
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Westman, & Lindergren, 1999, p. 1791). “The main difficulty is that [pain] is a person’s
private experience, to which no one else has direct access”
Dementia of the Alzheimer’s Type (DAT) is the most common cause of dementia
(Alzheimer's Association, 2009) The number of persons with DAT in the United States is
estimated between 4 to 6 million (Alzheimer's Association, 2009; Hebert, Scherr,
Bienias, Bennett, & Evans, 2003) and current estimates are that DAT cases will grow to
16 and 17 million by the year 2050 (Alzheimer's Association, 2009; Hebert, et al., 2003).
Beatty (2006) reports that 10% of adults over the age of 65 and 50% over the age of 90
have dementia, while Chung (2006) estimated that 4-12% of older adults have dementia
and/or cognitive impairment (CI).
Many older adults do not receive adequate pain management. Between 40% and
80% of community-dwelling older adults (Pahor, et al., 1999; Woo, Ho, Lau, & Leung,
1994) and 16% and 25% of nursing home residents (Feldt, Ryden, & Miles, 1998; Horgas
& Tsai, 1998; Lichtenberg & McGorgan, 1987) receive no pain medication. Bernabei and
colleagues (1998) found that 25% of elderly patients who reported daily pain received no
analgesics.
Cognitively intact individuals can report their pain and nurses can then intervene.
However, we have known for several years that individuals with mild, moderate, or
severe cognitive impairment present specific assessment and management problems for
nurses (Beck, et al., 1998; Happ, 2000; Harvath, 1994; Kolanowski, Litaker, & Buettner,
2005) with many individuals unable to self-report pain (Feldt, et al., 1998; Ferrell,
Ferrell, & Rivera, 1995; Hadjistavropoulos, Craig, Martin, & et al., 1997; Horgas &
Miller, 2008; Tsai, et al., 2008) For example, Weiner (1998) reported that only 30-50%
of adult day care participants with mild and moderate CI could report pain. Self-report
becomes impossible as dementia progresses because individuals lose the ability to
communicate.
Assessment using behavioral markers becomes unreliable among individuals with
severe CI (Gagliese, 2001; Herr, Bjoro, & Decker, 2006; McCann, Gilley, Hebert,
Beckett, & Evans, 1997; Monroe & Carter, 2009) because severe CI blunts behaviors
(Beck, et al., 1998; Monroe & Carter, 2009; Reisberg, 1984; Stevenson, Brown, Dahl,
Ward, & Brown, 2006). Assessment relaying on verbal reports becomes unreliable
because severe CI blunts speech (Farrell, et al., 1996; Herr, et al., 2006). Therefore,
nurses do not have clear evidence-based methods to assess and manage pain in the very
severely cognitively impaired older adults and evidence based practice is necessary in
order to sustain the profession of nursing (Algase, 2006).
Drawing generalizations from the nursing literature with regard to pain
assessment and gauging a resident’s mental status is problematic, however, since few
authors accurately distinguish dementia, CI, and CI without dementia. For example,
Ferrell, Ferrell, and Rivera (1995, p. 597) comment that “Cognitive impairment
(dementia or delirium) is a substantial barrier to pain assessment in this population.” Here
the authors imply that CI is equivalent to dementia or delirium, when in fact CI is one
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facet of a differential diagnosis of dementia. Therefore, it would be useful to provide
specific definitions of those conditions pertinent to this study, CI and dementia.
HISTORY OF HOSPICE
Dr. Cicely Saunders began modern hospice at St. Christopher’s near London in
the 1960’s as the first program to use aggressive pain management for dying individuals.
Dr. Saunders believed in effective symptom control, caring for the individual, and family
(Marx, 2007; Parham, 2002).
In 1963, Dr. Saunders visited Yale University where she presented her model to a
group of healthcare professionals including the Dean of the Yale School of Nursing,
Florence Wald. Dr. Wald was so impressed she began working to bring hospice to the
United States (Parham, 2002). During this time, Elisabeth Kubler-Ross published On
Death and Dying based on hundreds of interviews with dying patients. Kubler-Ross
believed that individuals had the right to die at home. Ultimately through their efforts,
Hospice came to the United States in 1974 located in New Haven, Connecticut and in
1977 the National Hospice Organization (NHO) was founded (Parham, 2002).
ASSESSING PAIN IN NURSING HOME RESIDENTS WITH COGNITIVE
IMPAIRMENT
Instruments
The Discomfort Behavior Scale (DBS) (Stevenson, et al., 2006) was developed as
an alternative to self-report and surrogate pain ratings for older adults with cognitive
impairments. The DBS is a 17-item instrument derived from assessment items on the
Minimum Data Set (MDS) 2.0 (U. S. Department of Health and Human Services,
2000a) that address behaviors that may indicate discomfort related pain. The MDS is a
comprehensive tool that is used to assess all residents in U.S. nursing homes. The
assessment includes demographic and diagnostic variables, as well as clinical, functional,
psychosocial, and cognitive assessments. Full MDS assessments are required at the time
of admission and on the annual anniversary of admission. Shorter assessments are
completed quarterly and following significant changes in the resident’s status (U. S.
Department of Health and Human Services, 2000a). Clinicians and care providers should
be aware of biases and inconsistencies occurring from surrogate pain ratings (Engle,
Graney, & Chan, 2001; Horgas & Dunn, 2001) such as those required for the initial MDS
assessment, the State of the Art Review of Tools for Assessment of Pain in Nonverbal
Older Adults (as cited in Herr, Bursch, Miller, & Swafford, 2010). This means that the
reliability of the DBS is dependent on the potential variability inherent in the MDS.
Initial conceptualization of the DBS was developed with four experts in pain
assessment in cognitively impaired older adults reviewing the content validity of the
DBS. Item construction was taken from specific MDS data believed to be behavioral
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indicators of discomfort and potentially discomfort related pain. Content validity was
established by reviewing 20 MDS items; 8 from section E1 (indicators of depression,
anxiety or sad mood), 10 from section E4 (indicators of behavioral problems such as
wandering or resisting care), and 2 from section G1 (self performance such as ability to
walk) (Herr, Bursch, & Black, 2008; Stevenson, et al., 2006). There was 100% agreement
on 19 items and 2 other items related to walking were dropped because they would bias
non-mobile residents (Herr et al., 2008).
Next, exploratory (EFA) and confirmatory (CFA) factor analysis were conducted
to confirm single discomfort factor dimension. This single dimension was then confirmed
in a third sample to confirm the DBS score (Stevenson et al., 2006). EFA demonstrated a
single discomfort dimension with a goodness of fit .068. Eigenvalue structure indicated
42.4% of the variance explained by the single discomfort dimension (Herr, et al., 2008;
Stevenson, et al., 2006). CFA with second sample supported the construct of a single
discomfort dimension with CFI = 0.977, TLI = 0.974, and RMSEA = 0.068 (Stevenson,
et al., 2006). The third sample used to test the model demonstrated good fit with CFI =
0.955, TLI = 0.955, and RMSEA = 0.087.
Composite reliability of the DBS was .98, with a Chronbach’s alpha of .77 and a
shared variance of .76 (Stevenson, et al., 2006) indicating that only 24% of the average
variance is related to error (Herr, et al., 2008; Stevenson, et al., 2006). Interrater or
Intrarater reliability was not reported in the original study. The authors found each item
in the DBS to be tau equivalent with good internal consistency (Stevenson, et al., 2006).
The DBS is scored from 0 – 102 and factor analysis showed that the DBS is able to
discern a single discomfort dimension (Stevenson, et al., 2006). The original study (N =
29,120) was a large epidemiologic study of cognitively impaired individuals in
Wisconsin, USA using the MDS 2.0 (Stevenson, et al., 2006).
Stevenson and colleagues (Stevenson, et al., 2006)compared DBS scores with
categorical Cognitive Performance Scale (CPS) scores. The CPS is a reliable and valid
measure of cognitive decline that also uses specific MDS items (Paquay, et al., 2007).
The CPS is scored from 1 (borderline intact) to 6 (very severe impairment). Stevenson
and colleagues studied moderate to very severe impairment (CPS 3 – 6) and found that
DBS scores increased with increasing levels of cognitive impairment, except for the
highest level of impairment (CPS = 6) and hypothesized that severe CI may blunt the
outward signs of discomfort (Stevenson, et al., 2006).
The Cognitive Performance Scale (CPS) (Morris, et al., 1994) was developed
from five MDS items and is reported both reliable and valid when an individual is trained
on its use (Paquay, et al., 2007). The CPS is scored from 1 to 6 indicating borderline
intact to very severe impairment. Wu and colleagues (2003) quantified the severity of
cognitive impairment with the CPS into three categories, no or mild CI (0-1), moderate
CI (2-3), and severe CI (4-6). They reported that scores of 4-6 have been reported to
correlate with a MMSE score of <10, indicating severe CI while CPS scores of 5 and 6
are equivalent to an MMSE of <5 (Hartmaier, et al., 1995; Morris, et al., 1994) indicating
very severe impairment.
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Feldt (2000) found that older adults with CI could successfully complete basic
verbal pain instruments and that these reports are both reliable and valid, while Stolee, et
al. (2005) reported that completion rates on instruments that measure intensity appear to
be highest such as the Pain Thermometer and Numerical Rating Scale. For example, they
found that 90% of older adults with mild CI and 100% of older adults with moderate CI
could complete the Faces Pain Scale, the Present Pain Intensity Scale (PPI), and the
Memorial Pain Assessment Card (MPAC). Kamel, Phlavan, Malekgoudarzi, Gogel, and
Morley (2001) confirmed the usefulness of instruments in assessing a nursing home
resident’s specific level of pain over asking him or her for a self-report. Among residents
given three basic instruments (verbal pain scale, visual analogue scale, and the faces
scale), reports of pain increased 50% over those residents who were simply asked “Do
you have pain?”
Verbal descriptor scales such as the PPI are considered advantageous for their easy
and quick administration. However, the adjectives used in the scales may hinder the
patient from responding, since he or she may not be able to understand or identify the
word used as the descriptor of pain (DeWaters, 2003). Freeman et al. (2001) compared
residents’ results in using the Visual Analogue Scale (VAS), a 0–100 mm line, and the
Faces Rating Scale (FRS), a series of six faces.
The current state of instrument development among non-verbal and severely
cognitively impaired individuals is in its infancy. Herr and colleagues (2006) conducted a
state of the science review on ten pain behavior instruments. Herr and colleagues’(2006)
review showed promise for several instruments and ultimately recommended further
testing. Currently there is no behavior instrument with proven reliability and validity for
use in the non-verbal and severely cognitively impaired individual (Bjoro & Herr, 2008).
Methodological Problems Measuring Pain
The International Association for the Study of Pain (IASP) provides one widely
accepted definition of pain which reads, “Pain: An unpleasant sensory and emotional
experience associated with actual or potential tissue damage, or described in terms of
such damage” (International Association for the Study of Pain, 1979, p. 250). The
difficulties in the subjective nature of pain are summed up by Johansson, Hamburg,
Westman, & Lindgren (1999, p. 1791), “The main difficulty is that [pain] is a person’s
private experience, to which no one else has direct access.” McCaffery (1999, p. 8)
defined pain as, “Whatever the experiencing person says it is, existing where ever he says
it does.” If according to these recognized definitions of pain, a person must understand
and report pain, then the person must be able to recognize and describe the experience of
pain. This is clearly a problem for people with cognitive impairments.
How one interprets his/her own quality of pain is key in establishing reliability
and validity in the cognitively impaired elderly person (Ferrell, Stein, & Beck, 2000).
Feldt (2000, p. 14) summarized threats to validity when assessing pain in older persons
with CI, “Impaired verbal skills and the ability to abstract concepts further obstruct
assessment in pain for this population.” According to Ferrell et al. (2000, p. 1669), “Valid
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and reliable assessment of pain relies on individual patient interpretations and selfreport.” Additionally, Feldt (2000) pointed out decreased reliability inherent in many pain
assessment tools used in the cognitively impaired that rely on memory of previous
painful experiences. Bjoro and Herr (2008, p. 246) stated, “Observational approaches to
pain assessment rely on interpretations of behaviors. The inherent subjectivity involved . .
. represents challenges to the reliability and validity of pain assessments.” As such, there
is currently no reliable or valid observational tool recommended for clinical practice
(Bjoro & Herr, 2008).
Pasero and McCaffery (2001) argue that the only reliable information about pain
must come from the patient. Hanson et al. (2008) reported that among nursing home
residents with CI, 42% could express pain verbally; Ferrell (1995) found that 62% of
nursing home residents with mild and moderate CI were able to report pain, and 83%
could use one of five pain instruments (Ferrell, et al., 1995). The challenge, therefore, is
to find a reliable and valid instrument that will be useful in residents with CI who are in
many instances nonverbal.
Methodological Problems Measuring Cognitive Impairment
The Mini-Mental State Examination (MMSE) is the most frequent research and
assessment tool for measuring CI and measuring cognitive status (Chopra, Cavalieri, &
Libon, 2007; Tombaugh & McIntyre, 1992). There are inconsistencies and improper
usage of the MMSE found in research literature.
The MMSE was not designed to be the sole determinant of dementia and is
intended to be used only as a screening device for impairment (Chopra, et al., 2007;
Decker & Perry, 2003; Folstein, 1975; Teng & Chui, 1987; Tombaugh & McIntyre,
1992; Weiner, 1999). Screening means that dementia likely exists. The MMSE is not
reliable in persons with less than an eighth grade education and in persons who are not
fluent in spoken English (Tombaugh & McIntyre, 1992). Heye (1997, p. 136) pointed out
that screening for CI can be facilitated with the MMSE but the client must be able to
speak, hear, and see. Weissman and Matson (1999, p. 34) shared concerns with CI that
would directly affect administration of the MMSE related to hearing, visual impairment,
language, attention span, and cognitive ability affecting the assessment process. Lehmann
& Rabins (1999, pp. 180-181) stressed CI should only be a part of the mental state
examination: “The complete mental status examination, however, always [emphasis
added] includes attention to the following areas: general appearance, speech, mood,
suicidal ideation, abnormal thought content, and cognitive assessment.” The MMSE only
touches on a few of these components, speech and cognitive status.
The MMSE is probably the most popular tool for measuring cognitive status
(Chopra, et al., 2007), but it was designed to be used only as a screening device for levels
of impairment (Chopra, et al., 2007; Folstein, 1975; Teng & Chui, 1987; Tombaugh &
McIntyre, 1992). There are additional issues to be addressed when using the MMSE as a
research tool in assessing nursing home residents with CI: their educational level, sensory
status, and language fluency, for example. Some researchers, such as Tombaugh and
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McIntyre (1992) have suggested that comparing MMSE scores across multiple studies
may be difficult because a variety of ranges of impairment have been used. An example
may be 26-30 no CI, 21-25 MCI, 16-20 moderate CI and 15 or less indicating severe CI.
SUMMARY
In the U.S., 25% of adult deaths each year now occur in nursing homes (30% in
the first year), and the prevalence of dementia and pain or painful conditions may be as
high as 82% in these settings. This means that approximately 800,000 people die in
nursing homes and nearly 650,000 of these have dementia prior to demise. In addition,
more than 50% of nursing home residents have pain and as many as 90% of those with
cancer have pain. In 1989, the federal government extended hospice benefits to residents
in nursing homes and in 1996 established diagnostic guidelines for admitting persons
with dementia, but as shown above a large majority of hospice-eligible residents,
especially those with CI, never benefit from its services. A major goal of this study is to
document the impact of hospice on the terminally ill nursing home resident with CI who
suffers significant pain and thus diminished quality of life. Its primary research question
involves the identification of differences in pain assessment, pain management, and
medication administration between two populations: nursing home resident with CI who
received hospice services and residents with CI who did not. Instruments used to measure
pain in persons with cognitive impairment are in the infancy stage of development. Most
instruments rely on behavioral discomfort or pain cues. Determining the feasibility of
using behavioral instruments among the more severely cognitively impaired is a
secondary goal of this study.
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CHAPTER 3. HOSPICE IN U.S. NURSING HOMES: BENEFITS AND
BARRIERS*
INTRODUCTION
There is general consensus among experts that nursing home residents in the
United States do not receive adequate pain management (Herr & Decker, 2004) or highquality palliative care, especially symptom management at the end of life (Duncan,
Forbes-Thompson, & Bott, 2008; Hanson, Sengupta, & Slubicki, 2005). Hospice can
positively benefit end-of-life symptom management where about a fourth of adult deaths
in the U.S. now occur (Ersek & Wilson, 2003; Hanson, Sengupta, et al., 2005). Almost
50% of nursing home residents have dementia (Magaziner, et al., 2000) and the
prevalence of pain or painful conditions is estimated to be between 49% and 83% among
residents with dementia (Bjoro & Herr, 2008). This means that of the approximately
800,000 residents in the U.S. who die in nursing homes, over 400,000 have dementia and
650,000 have pain. Enrollment in hospice at the end of life in the nursing home is one
way to improve care for these residents. Currently, 2% of residents are enrolled in
hospice upon admission (Parker-Oliver, Porock, Zweig, Rantz, & Petroski, 2003) while
6% (Miller, Mor, & Teno, 2003) of nursing home residents are enrolled in Hospice prior
to death. Finding ways to improve hospice enrollment among nursing home residents,
especially those with dementia and pain, remains a clear challenge.
In 1996, Medicare hospice services were extended to terminally ill older adults
with severe cognitive impairments (Cherney, 2008). These new guidelines covered many
nursing home residents who were not previously eligible for hospice. Countless older
adults with severe cognitive impairment, especially those with Alzheimer’s disease, live
and die in nursing homes which by 2003 was the fifth principal cause of death among
individuals over the age of 65 in the U.S. (Mitchell, 2007). Hospice services can offer
nursing home staff and families support while simultaneously helping manage pain,
providing comfort, and easing the transition to death in older adults with cognitive
impairment.
Since the approval in 1989 of a Medicare Hospice Benefit (MHB) (Centers for
Medicare and Medicaid, 2008; Munn, et al., 2006), nursing homes have been able to offer
a wide range of hospice services to dying residents (Figure 3-1). However, fewer than
half of residents who are hospice eligible actually receive the benefit (Munn, et al., 2006).
Miller and colleagues (2002), found that while 24% of nursing home residents were
hospice eligible, only 6% of dying residents used the benefit, while Evans (2002)
reported that only 1% of nursing home residents use the benefit, and fully 70% of all
nursing homes have no resident enrolled in hospice (Keene & Thompson, 2008; Petrisek
& Mor, 1999). These studies show an under use of hospice in nursing homes.
*Reprinted with permission from Monroe, T & Carter, M. (2010) Hospice care in US
nursing homes: benefits and barriers. European Journal of Palliative Care, 17(3),144149.
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Eligible for Part A of Medicare
Terminally ill with a life expectancy of 6 months or less
Physician and Advanced Practice Nursing (APN) services*
Medical care through the hospice Medical Director
Nursing Care
Case Management
Medical appliances and supplies
Medications related to the terminal illness and palliation of symptoms
Speech therapy
Short-term inpatient and respite care
Physical and occupational therapy
Dietary counseling
Homemaker and home health aide services
Continuous care
Counseling and social work services
Spiritual care
Volunteer participation
Bereavement services
Two 90-day certification periods†
An unlimited number of subsequent 60-day periods

Figure 3-1 The Medicare Hospice Benefit
* The first 90-day hospice certification must be approved by the beneficiary’s
attending physician and the hospice medical director. The remaining 60-day
periods require only 1 physician.
† In 2004, the US Congress and Centers for Medicare and Medicaid Services
developed new provisions in hospice care as a result of the Medicare Act of 2003:
the definition of attending physician was changed to include nurse practitioners
(NPs); however, nurse practitioners cannot certify a patient’s terminal illness as
the physician.
Adapted with permission from Centers for Medicare and Medicaid (2008) The Medicare
hospice benefit. Retrieved November 24, 2008, from
http://www.medicare.gov/publications/Pubs/pdf/02154.pdf
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The purpose of this manuscript is to provide a broader understanding of hospice
in nursing home settings by detailing the multiple benefits of its end-of-life care. Hospice
care for nursing home residents with dementia and/pain is better when measured by
documentation of assessment and administration of medications, documentation of
receipt of alternative therapies, and documentation of fewer prescribed and administered
inappropriate medications for use in the elderly. Hospice use is less costly to the total
health care dollar because it decreases futile care at the end of life and reduces
unnecessary hospitalizations. Barriers to hospice use in nursing homes are detailed,
followed by a discussion of what nurses and others can do to increase hospice enrollment
among nursing home residents.
BENEFITS OF HOSPICE IN NURSING HOMES
Better Pain and Symptom Management
Nursing home residents receive several benefits from using hospice. Pain
management has been a concern among nursing home residents for nearly 30 years
(Ferrell, Ferrell, & Osterweil, 1990). More recently, investigators found that 86% of
dying nursing home residents had pain and 53% of those had moderate to severe pain
(Reynolds, et al., 2002). Hospice can provide several benefits for nursing home residents
and pain management appears to be one advantage. One study showed that longer-stay (7
days or more) nursing home residents in hospice had a greater (AOR = 5.4; 95% CI 1.3,
21.7) likelihood of receiving an opioid and a greater (AOR = 2.7; 95% CI 0.9, 7.7; p =
0.07) likelihood of receiving an opioid twice a day (Miller, et al., 2003). Other
researchers found that residents enrolled in hospice were more likely to receive opioids
for pain and two times more likely to have a documented pain assessment (Wu, et al.,
2003). Miller et al., (2002), reported the use of analgesic medication among hospice
enrollees in nursing homes was 50% greater than non-hospice enrollees (OR 0.57; 95%
CI 0.45, 0.7) Munn and colleagues (2006) compared nursing home residents enrolled in
hospice and those who were not (N = 124). They found 85% of nursing home residents
had moderate to severe pain compared to 52% of those enrolled in hospice (p < .05) and
82% of hospice enrolled residents received pain medications compared to 50% of those
not enrolled (p < .05). Nursing home residents enrolled in hospice experience a 93%
(95% CI, 1.56 – 2.38) greater likelihood of having an attempt to manage documented
pain (U. S. Department of Health and Human Services, 2000b).
Researchers (2006) found that alternative pain management strategies such as ice
packs and massage were more often used among hospice residents (26% vs. 6%, p =
.004) and hospice residents were more likely to have assistance with eating (89% vs.
63%, p = .01) and oral hygiene (96% vs. 78%, p = .03). A meta-analysis of 19
hospice/palliative care studies revealed that pain was mildly better managed by
hospice/palliative care teams (OR = 0.38; 95% CI 0.23 – 0.64) and all other symptoms
were moderately better managed by hospice/palliative care teams (OR = 0.51; 95% CI
0.30 – 0.88) (Higginson, et al., 2003). Hospice is better at managing pain in nursing home
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residents when pain management is measured by residents receiving opioids or other pain
medications, or by the use of alternative therapies.
Better overall pain and medication management are recognized benefits among
residents using hospice. One study reported that hospice residents received fewer
inappropriate medications as recommended by the American Medical Director’s
Association (OR = 0.65; 95% CI 0.52-0.80, (Miller, et al., 2002).
Pain management may be better among all residents when hospice is used in the
facility, a phenomenon identified as the hospice effect. One possible cause is that nurses
are reminded to assess and treat pain when they see hospice personnel in the building;
their mere presence acts as a cue to other staff to manage the pain of non-hospice
residents. Pain assessments were more likely in non-hospice individuals who resided in
facilities where hospice was present (Wu, et al., 2003). Another example of the hospice
effect is seen in cost savings to health care. Researchers found that non-hospice nursing
home residents hospitalizations decrease as hospice enrollment increased (U. S.
Department of Health and Human Services, 2000c).
Residents enrolled in hospice (N = 1,982) were compared with those who were
not (N = 6,392) (U. S. Department of Health and Human Services, 2000c). Detection of
daily pain (as documented on the last MDS prior to death) was different among the
groups. Residents enrolled in hospice with cancer and no dementia (n = 430), had daily
pain (28.1%) and among those with cancer and dementia (n = 717), 16.0% experienced
daily pain. Residents not enrolled in hospice with a diagnosis of cancer and no dementia
(n = 1,529) had a pain detection rate of 16.8% and those not enrolled in hospice with a
diagnosis of cancer and dementia (n = 2,293) had a pain detection rate of 8.9% (U. S.
Department of Health and Human Services, 2000c). These same researchers found that
among residents with dementia enrolled in hospice (n = 394) pain was detected in 11.4%
compared to 5.0% among residents with dementia not enrolled in hospice, and for all
“other” diagnoses enrolled in hospice (n = 441) pain was detected 17.5% of the time
compared to a 7.8% pain detection rate for all “other” diagnoses non enrolled in hospice
(U. S. Department of Health and Human Services, 2000c). This means that while hospice
enrollees have better pain detection across the board, those residents diagnosed with
cancer or cancer and dementia that are enrolled in hospice experience more frequent pain
detection resulting in better quality of care.
Financial Benefits
A final benefit may be evident in the costs savings to the health care system.
Greater hospice enrollment may help ease the burden on the U.S. healthcare system, since
health utilization costs decrease when residents are not constantly transported to and from
the hospital and do not use acute care facilities (Susan L. Mitchell, et al., 2004).
Investigators found almost half (43.7%) of nursing home residents compared to 31.5% (p
= .001) with dementia (CPS score = 5 or 6) were hospitalized at least one time during the
last 90 days of life (Susan L. Mitchell, et al., 2004) and decreasing just one hospital day
per Medicare beneficiary can save the US health care system millions of dollars
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(Kronman, Ash, Freund, Hanchate, & Emanuel, 2008). This means that residents with
dementia and cognitive impairments are transported to hospitals more frequently (Teno,
et al., 2004), when available hospice care can help relieve pain and provide support to the
resident and family. Researchers found that more primary care visits in the year
preceding death equated to fewer hospitalized days prior to death possibly attributed to
increased opportunities to prevent medical complications and coordinating palliative
home care (Kronman, et al., 2008).
According to the U.S. Department of Health and Human Services (2000c),
nursing home residents who use hospice are significantly less likely to be hospitalized in
the last 30 days of life than those residents who do not (12.5% vs. 41.3%), in the last 90
days (24.5% vs. 53%), and in the last 6 months (39.8% vs. 61.6%). More specifically,
residents who use hospice save Medicare an average of $2309 per hospice user when
compared to non-hospice decedents (p = .001) (Taylor, Ostermann, Van Houtven,
Tulsky, & Steinhauser, 2007) and the U.S. Department of Health and Human Services
(2000c) found the reduction in hospitalizations in the last 30 days translated into acute
medical care savings of $2909 per resident.
Investigators found that 25% of hospice users were enrolled for less than one
week (Taylor, et al., 2007; U. S. Department of Health and Human Services, 2000b) and
50% are enrolled less than 30 days (U. S. Department of Health and Human Services,
2000c). Individuals with cancer save Medicare the most ($7000) while other primary
conditions save $3500 noting that after 6 months of hospice, the savings to Medicare
cease but do not increase over the non-hospice users (Taylor, et al., 2007). Residents who
received information about palliative care and subsequent assistance enrolling in hospice
had fewer acute care admissions (mean 0.28 vs. 0.49; p = .04) and experienced fewer
hospitalized days (mean: 1.2 vs. 3.0; p = .03) (Casarett, et al., 2005). Thus, efforts to
increase short-stay hospice offer a greater opportunity to save Medicare dollars over
attempts to reduce long-stay hospice (Taylor, et al., 2007; U. S. Department of Health
and Human Services, 2000b) and increasing the length of enrollment in 7 out of 10
nursing home residents would greatly increase savings (Taylor, et al., 2007). Hospice
could also help the financial picture of the nursing home in that the facility would be paid
the daily rate rather than lose this payment during the resident’s hospitalization.
BARRIERS TO HOSPICE USE
Patient and Family Barriers
In some situations, a family’s culture and religion may influence their decisions
concerning hospice enrollment for their loved one. According to Jablonski and Wyatt
(2005), Hispanic and African American families generally favor life-sustaining measures
over palliative care, which may conflict with caregivers’ attempts to offer pain relief.
Certain spiritual and religious traditions, such as a belief in God or higher power, may
help individuals cope with the dying process and associated pain. The family may believe
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that everything that can possibly be done must be done and life sustained at all costs even
when this increases suffering of the resident and the family.
Other resident and family barriers to hospice include patient preferences for lifesustaining treatment, perhaps indicating a lack of understanding by the patient and family
about the terminal nature of the diagnosis (Casarett, van Ness, O'Leary, & Fried, 2006),
or perhaps a desire to not surrender to the disease. Casarett and colleagues (2004) found
56% of patients and families were reluctant to accept the terminal nature of the diagnosis
and most (91%) hospice-eligible older adults did not enroll until late in the course of a 6month illness. Among residents enrolled in hospice, one third had been there less than 2
weeks and one fifth less than 1 week (Dobbs, et al., 2006; Miller, et al., 2003). These
studies suggest that in many circumstances, patients are not receiving the full benefit of
hospice because of late enrollment. More education on hospice practices, and its
provision earlier in the course of a patient’s likely terminal illness, would help address
these issues. However, the likely reluctance of ‘giving up’ that is implied by engaging in
hospice poses a significant barrier to enrollment.
There are barriers to hospice enrollment that are specific to residents with
dementia and/or severe cognitive impairment. One study found only 1 in every 10
persons dying with dementia were enrolled in hospice (Sachs, Shega, & Cox-Hayley,
2004). This low enrollment is likely the direct result of communication problems between
residents and staff and 17% of nursing home nurses believe that hospice staff do not have
the skills to care for residents with dementia (Tarzian & Hoffmann, 2006). This finding is
interesting given that 59% of nursing home residents using hospice experience some
cognitive impairment (Reynolds, et al., 2002). Mitchell, Kiely et al., (2004) reported that
residents with cognitive impairments who are admitted to nursing homes had more
functional disability, behavior problems, and tube feedings likely contributing to lower
hospice enrollment. The authors also found that this cohort is often not recognized as
terminally ill, with very infrequent (5.4%) referrals to hospice (Susan L. Mitchell, et al.,
2004). Communication difficulties between residents and nurses and difficulty
recognizing deteriorations in health make enrolling residents with dementia difficult.
Educating staff and family on the benefits of hospice use among residents with dementia
could help to increase enrollment. Determining when a resident becomes terminal is not
easy.
A majority of hospice nurses (88%) and 45% of nursing home nurses believe that
lack of knowledge about hospice on the part of residents and families is a barrier to
hospice use (Tarzian & Hoffmann, 2006). Hospice enrollment increased after a brief
structured interview between a clinician and nursing home residents and their families.
The interview included information about the hospice philosophy and appropriateness for
the resident. Within 30 days, 20% of the intervention group reported enrollment, versus
1% for the nonintervention group (p <. 001) (Casarett, et al., 2005). The resident’s
physician initiated hospice if appropriate after receiving a data sheet suggesting a
potential fit for hospice. Another study revealed that 85% of patients and families decided
to enroll in hospice after one conversation (Casarett, et al., 2004). One effective strategy
to increase hospice enrollment that can be initiated by nurses or physicians appears to be
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simple communication to residents and families about hospice and its role in end-of-life
care.
Nursing Home Staff Barriers
Lack of knowledge about and familiarity with hospice and palliative care on the
part of nursing home staff is one barrier to its full utilization in such settings. A study of
nursing home and hospice nurses found that 92% of hospice nurses and 26% of nursing
home nurses believed that a lack of knowledge about hospice on the part of the nursing
home staff was a barrier to hospice enrollment (Tarzian & Hoffmann, 2006). Symptom
relief is a major tenet of palliative care and overall symptom burden is higher among
nursing homes than residential care or assisted living facilities (19.8% vs. 16.8%, p = <
.001, (Hanson, et al., 2008). Jablonski and Wyatt (2005) explained that the problem of
symptom relief in nursing homes may be exacerbated by the large numbers of unlicensed
personnel lacking palliative education providing a majority of the care. In one study,
nearly 20% of nursing homes did not provide formal training in end-of-life pain and
symptom management and more than 50% of nursing home administrators believed that
educational deficits were the single greatest obstacle to providing quality end-of-life care
(Rice, Coleman, Fish, Levy, & Kutner, 2004). Unfortunately, the study by Hanson and
colleagues (2008) found that nursing home staff had no recommendation or suggestion
for improving symptom relief of pain (87%), dyspnea (89%), or cleanliness and oral
intake (90%) at the end of life. All of these factors may create higher levels of family
dissatisfaction with care, greater patient discomfort at the end of life, and increased
chances that staff will not recognize a resident’s eligibility for hospice.
Organizational and System Issues Barriers
Another perhaps more determinant barrier is rooted in the core philosophical
differences between traditional nursing home care which is on health maintenance, and
established hospice practice which is palliative (Table 3-1). These differences are
complicated by the documentation system used in nursing homes. The Minimum Data
Set (MDS) focuses on restorative rather than palliative care (Evans, 2002; Tarzian &
Hoffmann, 2006) and is required on each admission and quarterly thereafter. For
example, the MDS focuses on health and functional indicators (Hoffman & Tarzain,
2005) and does not promote symptom management such as pain control, dyspnea, end-oflife issues, fatigue, or spiritual needs (Evans, 2002). An illustration of this policy conflict
exists where the MDS mandates that evidence of a resident’s malnourishment be
redressed; however, if the resident is dying decreased food intake may be part of the
dying process and prolongation can actually increase suffering (Evans, 2002; Hoffman &
Tarzain, 2005; Tarzian & Hoffmann, 2006). Clearly, palliative care is not supported by
the current MDS and improvements to the documentation system are needed.
The resident plan of care potentially creates a significant barrier to enrollment.
Parker-Oliver (2002) found among administrator’s and directors of nursing (DON’s) (N =
60) confusion existed over the ultimate responsibility of the care of the resident with
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Table 3-1 Differences in Care between Nursing Homes and Hospice*
Care Characteristic
Curative or Restorative Care

Nursing Homes
Yes

Hospice
No

Palliative Care

Sometimes

Always

Amount of Technical Care Work
(charting, taking vital signs,
hygienic care, etc.)

High

Low

Amount of Relational Care Work
(spiritual or psychological
counseling, listening)

Low

High

Care Recipient

Resident

Resident & Family

Care Provided by Volunteers

Seldom

Often

Grief Counseling
Seldom
Always
*Adapted with permission from Parham, L. (2002) . Contrasts in care work: Hospice care
in nursing homes (Doctoral Dissertation). Accessed July 17, 2008, from
http://fs.aleph.fcla.edu/F/5BX3Y1FQMCI2V69V2XU9SVSU1QIYF21959T96J4L8FUB
6HX532-31842?func=full-set-set&set_number=002202&set_entry=000001&format=999
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36% of respondents believed that the nursing home and hospice were responsible for the
palliative plan of care, 18% identified hospice, and 6% did not know. Among this same
cohort, only 38% believed they understood how hospice was reimbursed and 15%
believed that hospice and nursing home boundaries were not clear (Parker-Oliver &
Bickel, 2002). Another study of hospice nurses (N = 69) found that one third defined
communication/miscommunication as one of the biggest problems working with hospice
patients in nursing homes (Parker-Oliver, 2002). This means that lack of understanding
about hospice and nursing home plans of care may lead to gaps in care, gaps in
reimbursement, and potential liability. For example, the nursing home and hospice may
establish two different wound care plans for the same patient. The resident lives in the
nursing home making the nursing home liable, not the hospice, since this nursing home is
responsible for the overall plan of care.
Staffing shortages (Ersek & Wilson, 2003) and high employment turnover (Evans,
2002) contribute significantly to low quality end-of-life care (Hanson, Sengupta, et al.,
2005; Rice, et al., 2004). Nursing home staff are generally the lowest paid in the industry
(Ersek & Wilson, 2003) and this makes recruitment and retention very difficult.
Investigators found turnover rates in Texas nursing homes were 133% for registered
nurses, 108% for licensed vocational nurses, and 160% for certified nursing assistants
(Kash, Castle, Naufal, & Hawes, 2006) and many nursing homes in Kansas also
experience greater than 100% turnover for all staff (Clarkin, 2008). Nursing home
administrators also experience high turnover. Castle (2001) discovered 43% of nursing
home administrators quit prior to completing one year of employment. Staffing shortages
and high attrition make detailed assessments difficult, and most of the care is provided by
licensed practical nurses with less education, especially in end-of-life care. This means
discontinuity can occur between the hospice plan of care and the nursing home plan of
care resulting from frequent staff turnover.
Conflicts between hospice staff and nursing home staff also serve as a barrier to
hospice use in nursing homes. Both hospices and nursing homes are regulated by the state
and each has a different organizational structure and culture. Hospices provide “relational
care” where nursing homes provide “routinized care” (Parham, 2002, p. 14). Relational
care is more democratic with the resident and family having more choices and routinized
care is very structured and bureaucracy driven (Parham, 2002). As a result, relationships
between hospice and nursing homes staff can become strained, negatively impacting the
resident’s care. Tarzian and Hoffman (2006) found that many nursing home staff
believed that hospice staff were not familiar with nursing home policy and believe that
most hospice staff rarely did anything that nursing home staff did not do. Another
conflict was shared by nursing home nurses feeling like hospice nurses “know
everything” and tend to “take-over” rather that work in a collaborative effort (Tarzian &
Hoffmann, 2006). Parker-Oliver (2002) found hospice nurses have the following
perceptions about nursing home nurses; 70% believe “hospice staff come and tell us what
to do, yet we are here 24 hours a day”, 54% believe “hospice puts everyone on
morphine”, and 53% believe “hospice just lets residents die”.
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Financial concerns have been commonly identified as barriers to hospice use,
particularly with regard to reimbursement and billing for specific services (Dobbs, et al.,
2006; Tarzian & Hoffmann, 2006). To cite but one example, Medicare’s Skilled Nursing
Benefit will pay for room and board, whereas Medicare’s Hospice Benefit will not. This
means that residents using the Medicare hospice benefit must find other resources to pay
for room and board including out of pocket, private insurance or Medicaid resulting in a
complicated and potentially lower reimbursement to the nursing home (Jablonski &
Wyatt, 2005). A second issue concerns reimbursement methods. Hospice agencies’
reimbursement to nursing homes tends to operate more slowly than government
healthcare agencies like Medicare and Medicaid (Evans, 2002). For example, if a resident
is Medicaid eligible, Medicaid will pay the hospice 95% or more of the state’s daily
nursing home rate, and then the hospice will reimburse the nursing home for room and
board complicating payment to the nursing home (Parham, 2002). Another
reimbursement concern is that nursing homes receive higher payment for rehabilitative
rather than palliative care, therefore revenue will be higher in nursing homes not using
hospice (Jablonski & Wyatt, 2005).
Other Barriers
Difficulty in determining the 6-month window to death, required by Medicare,
may serve as another barrier to hospice enrollment (Lorenz, Shugarman, & Lynn, 2006).
Many physicians’ are uncomfortable in estimating demise among residents, especially
those with dementia (Evans, 2002; Mitchell, 2007), congestive heart failure and chronic
obstructive pulmonary disease (Lorenz, et al., 2006) compared to those with cancer who
typically follow a predictable trajectory (Lorenz, et al., 2006). For example, one
instrument used to establish hospice eligibility for persons with dementia is the
Functional Assessment Staging (FAST) scale (Reisberg, 1988). However 40% of
residents in one study could not be evaluated with the FAST scale (Figure 3-2) because
their disease progression did not match FAST scale progression (Luchins, et al., 1997).
Episodic periods of deterioration and recovery are common in nursing home residents,
and this makes determining when the resident is in the final 6 months of life difficult.
This means that admission into hospice only need be determined by prognosis and
hospice can be renewed if they do not die within six months as long as the resident meets
the conditions for enrollment.
WHAT NURSES AND OTHER CARE PROVIDERS CAN DO TO INCREASE
HOSPICE ENROLLMENT
Education and awareness can have positive results on hospice enrollment. Hanson
et al., (2005) reported an increase in rates of hospice enrollment from 4.0% prior to an
educational intervention to 6.8% post-intervention (4.0%-6.8%, p = 0.01). Staff reported
an increase from 66% to 85% in their confidence to provide palliative care while
concurrently increasing hospice enrollment from 35 to 59 residents among the seven
nursing homes studied after participating in a 1-day educational program on palliative
care. Hospice access is also more likely when a contract exists between the nursing home
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Eligibility criteria for hospice using the FAST scale (must have both)
1. Functional Assessment Staging (FAST) level of stage 7c or beyond and evidence all
components of stages 6a-7c
2. The individual must have one of the following associated medical conditions within the
previous year*
FAST Stage 1: No objective of subjective difficulties
FAST Stage 2: Subjective reports of forgetting
FAST Stage 3: Decreased job functioning evident to coworkers. Difficulty traveling to new
locations
FAST Stage 4: Decreased ability performing complex tasks (e.g., planning dinner for guests,
handling finances)
FAST Stage 5: Requires assistance to choose proper clothes for day, season, or occasion
FAST Stage 6a: Cannot dress without assistance occasionally or more frequently
FAST Stage 6b: Cannot bathe without assistance occasionally or more frequently
FAST Stage 6c: Cannot toilet without assistance occasionally or more frequently
FAST Stage 6d: Incontinent of urine occasionally or frequently
FAST Stage 6e: Incontinent of bowel occasionally or frequently
FAST Stage 7a: Speech limited to fewer than 6 intelligible words during an average day†
FAST Stage 7b: Speech limited to a single intelligible word during an average day
FAST Stage 7c: Unable to ambulate independently
FAST Stage 7d: Cannot sit up independently
FAST Stage 7e: Cannot smile
FAST Stage 7f: Cannot hold head up independently

Figure 3-2. Determining Hospice Eligibility for Individuals with Dementia
*Associated Medical Conditions (must have one within previous year): Aspiration
pneumonia, pyelonephritis or other upper urinary tract infection, septicemia, decubitis
ulcer (multiple, stage 3-4), recurrent fever after treatment with antibiotics, eating
problems such that fluid or food intake is insufficient to sustain life (or, if tube fed,
weight loss > 10% over prior 6 months or serum albumin <2.5 g/dl).
†Stage 7a: In some geographical areas of the country, individuals with a FAST stage of
7a are eligible for hospice (Cherney, 2008).
Source: Adapted with permission from Mitchell, S. L. (2007). A 93-year-old-man with
advanced dementia and eating problems. Journal of the American Medical Association,
298(21), 2257-2536.
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and hospice (Rice, et al., 2004). Nurses and health care providers who are themselves
better educated on the benefits of hospice can provide education and awareness to
residents, their families, and the community positively improving hospice enrollment.
Many of these opportunities are currently available on-line (Table 3-2).
Braun and Zir (2005) developed the Appropriateness Care of Residents in
Nursing Homes (ACORN) to teach nursing home workers about end-of-life care.
Registered nurses and certified nursing assistants (CNAs) participated in the training.
ACORN training consisted of 8 interactive one-hour sessions located in 10 nursing
homes. Topics included: pain assessment and management, symptom management,
advanced directives, cultural issues and dying, and grief support. Pre and postintervention knowledge was significant (p = .01) among CNAs in all five categories
measured: comfort, knowledge of death and dying, grieving, facility deals with dying,
and pain management. However nurses reported only one area of significant (p = .01)
knowledge growth, facility deals with dying. Evidently, ACORN is better at helping
paraprofessionals increase their knowledge of end-of-life care. Residents, families, and
staff may benefit from an educational intervention such as ACORN. Nursing assistants
spend considerable time with residents and educational interventions that target these
individuals may well serve residents, families, and facilities. Paying for ACORN or other
educational training presents financial considerations for nursing home administrators.
SUMMARY
To summarize, there are many benefits to hospice use in nursing homes. First pain
and non-analgesic medication management is better among hospice enrollees possibly
attributed to the increased numbers of professionals participating in care including,
nurses, physicians, clergy, and social workers that have training in palliative care. Next,
greater symptom recognition and management occurs among residents enrolled in
hospice and this dually contributes to increased comfort for residents and better attitudes
from the resident and family favoring hospice services. A better relationship between
hospice personnel and residents and their families helps each to become more
comfortable with the terminal prognosis. Hospice can save significant health-care dollars
by reducing unnecessary expenditures associated with unnecessary end-of-life treatments
and frequent transfers from nursing homes to hospitals to expire.
Unfortunately, each of these benefits may not be realized because of any one or
combination of barriers to hospice enrollment. Often there are barriers associated with
family and resident knowledge deficits about hospice. These become evident when deep
rooted cultural beliefs conflict with hospice philosophy such as a preference for lifesustaining treatments. Inability of staff to recognize and manage end-of-life symptoms,
especially among residents with dementia hinder early hospice enrollment. Staffing
shortages and high turnover in nursing homes can directly affect hospice enrollment,
especially when attempting to keep staff trained on end-of-life care. Finally,
reimbursement issues and cultural clashes may hinder enrollment. Organizational clashes
exist between restorative nursing home guidelines and palliative hospice principles.
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Table 3-2 On-line End-of-life Educational Resources for Nurses
Resource
ELNEC

Description
Source for On-line Information
End-of-Life Nursing Education
Consortium offers a series of
modules designed to “train the www.aacn.nche.edu/elnec/
trainer” about end-of-life
issues

PERT

Palliative Care Educational
Resource Team provides
education to licensed and
unlicensed staff, including
decision-making skills and
end-of-life care for residents
with dementia

TNEEL

HPNA

Toolkit for Nurturing
Excellence at End-of-Life
Transition Program is based on
the American Association of
Colleges of Nursing’s
competencies in palliative
education
The Hospice and Palliative
Nurses Association provides a
wealth of information,
including position statements
and assistance with standards
of care

www.swedishmedical.org/PERT.htm

www.tneel.uic.edu

www.hpna.org

Wisconsin

Palliative Care Program at the
Medical College of Wisconsin

Rhode Island

Rhode Island Partnership to
Improve End-of-Life care:
“Train the Trainer” educational www.chcr.brown.edu/commstate
curriculum and “Continuous
Quality Improvement Project
in Pain Management”
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www.mcw.edu/pallmed

IMPLICATIONS
Much of the literature on increasing hospice enrollment in nursing homes is
focused on educational interventions. Many of the barriers identified warrant further
investigation beyond educational initiatives. Exploring cultural backgrounds or speaking
with a pastor may be the catalyst to hospice enrollment. Likewise, exploring potential
areas of liability for hospice in nursing homes are needed. In addition, many authors seem
to focus on the idea of hospice in the “home” setting and while the nursing home does
become a residents “home”, hospice brings different concerns into this setting.
Conflicts between nursing home and hospice staff may require a proactive
administrative lead. Techniques that increase individual empowerment could reduce this
friction. This means asking nursing home nurses to help determine which residents may
be hospice eligible and then reinforcing how hospice benefits the resident first, but may
inadvertently offer the nurse much needed assistance with care. Administrators who
invite hospices to bring “open houses” into the facility see the benefits of breaking down
these traditional organizational barriers creating a “win-win” situation for everyone.
However, careful consideration for hospice and nursing home policy and procedure are
needed. Administrators and staff who understand the rules and regulations of hospice and
long-term-care are better prepared to work together. This means that the continuity of
care receives less interruptions and the risk for liability is decreased.
More system-wide barriers may require stakeholders creating key policy
initiatives at the state and federal level. The MDS 3.0 will be available in 2009 and many
of the concerns related to lack of palliative care might be better addressed. Initiatives
creating transparent and sound reimbursement options between hospice and nursing
homes should be at the forefront of policy development. Nursing homes may continue to
seek higher paid interventions until equal reimbursement occurs for hospice, palliative,
and restorative care.
Identifying individuals who are terminal and expected to live less than 6 months
has been identified as a barrier to enrollment. This practice is the result of the Medicare
Hospice Benefit (MHB) requiring a physician to certify that a resident has less than 6
months to live. However, this should not be a significant barrier to enrollment. Residents
who meet recommended guidelines should be offered hospice services. Furthermore,
residents can be recertified for an indefinite number of recertification periods. A resident
and family can benefit from hospice for well more than 6 months. An educated family in
conjunction with a prudent physician and nurse practitioner can be a strong force for
initiating hospice services.
In conclusion, hospice has been helping individuals in the transition from life to
death with as little pain and discomfort as possible for nearly 30 years, but currently more
nursing home residents could be receiving the benefits of hospice than is now the case.
Nurses and healthcare professionals working in long-term facilities should be encouraged
to make a commitment to overcoming the barriers identified here to help increase hospice
enrollment and provide the best possible care for residents approaching the end of life.
Participating in on-line courses combined with on the job training is a first and important
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step to better prepare nursing home staff to manage terminal residents. However, much
more needs to be done at the system level through state and federal policy change.
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CHAPTER 4. METHODS
PURPOSE
The purpose of this study was to identify the differences in pain medication
administration between two different groups of deceased subjects, nursing home residents
with malignant cancer and dementia with and without hospice services.
DESIGN AND SETTING
This study was a retrospective study of pain medication administration in nursing
home residents who died with cancer and dementia and who received hospice services
compared to residents who did not receive hospice services. The last 14 days of life were
examined for this study.
Nursing homes throughout western Tennessee were recruited. Ten nursing homes
agreed to participate. One nursing home yielded no subjects leaving a final sample
consisting of nine nursing homes, seven non-profit and two for-profit.
This cross-sectional study explored the frequency, types, and amounts of pain
medication administered, while simultaneously a case-control design examined the
differences between a group of residents with hospice services and a group of residents
without hospice services for the relationships among pain, cancer, and dementia.
SPECIFIC AIMS AND HYPOTHESES
The primary aims of this study were (1) to determine the differences in
administered pain medications for cognitively impaired residents who died from cancer
while receiving hospice services as compared with those not receiving hospice services
and (2) to determine if discomfort related pain behaviors among nursing home residents
with cancer and dementia decrease with increasing cognitive impairment.
Specific Aim One
Specific Aim One was to determine the differences in administered pain
medications for cognitively impaired residents who died from cancer while receiving
hospice services as compared with those not receiving hospice services. The following
eight hypotheses were associated with this aim.


Hypothesis 1. Residents who received hospice services would receive more
scheduled narcotic analgesic than residents who did not receive hospice
services.
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Hypothesis 2. Residents who received hospice services would receive greater
total equivalent dose units (EDU’s) of narcotic analgesic than residents who
did not receive hospice services.



Hypothesis 3. Residents who received hospice services would receive greater
total dose number of non-narcotic analgesics (TDNN) than residents who did
not receive hospice services.



Hypothesis 4. Residents who received hospice services would receive more
PRN narcotic analgesic than residents who did not receive hospice services.



Hypothesis 5. Residents who received hospice services would receive more
scheduled non-narcotic analgesic than residents who did not receive hospice
services.



Hypothesis 6. Residents who received hospice services would receive more
PRN non-narcotic analgesic than residents who did not receive hospice
services.



Hypothesis 7. Residents who received hospice services would have different
cognitive performance scores (CPS) than residents who did not receive
hospice services.



Hypothesis 8. Residents who received hospice services would receive greater
total dose numbers of drug potentiators (TDNP) than would residents who did
not receive hospice services.

Specific Aim Two
Specific Aim two was to determine if discomfort related pain behaviors among
nursing home residents with cancer and dementia decrease with increasing cognitive
impairment. The following hypothesis is associated with this aim.
Hypothesis 9. Discomfort related pain behaviors among all residents will be
decreased with increasing cognitive impairment.
HUMAN SUBJECTS CONSIDERATION
Approval was obtained from the University of Tennessee Health Science Center
Review Board for the dates needed for data collection. Clarification and revision required
by the IRB was done. The study was approved and given exempt status (Appendix A)
and a revision for recruitment was approved (Appendix B).
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METHODS
The sample was drawn from nursing home residents with malignant cancer and
dementia in nine nursing homes in western Tennessee. The facilities were a mix of for
profit (n = 7) and nonprofit (n = 2) with a size range of 68 to 180 beds.
Inclusion criteria were residents who resided and died in a nursing home between
January 1, 2003 and July 1, 2009 with malignant cancer and dementia. Initial subject
recruitment began by using Vista KEANE MDS® software in each nursing home (Keane
Care Inc. Redmond WA). Prospective subjects were located using the following
methodology: First, 10 malignant cancer codes were used to search “client by diagnosis”.
“Client by diagnosis” is a default option in the software used to locate nursing home
residents with specific traits. The cancer diagnoses as described in chapter 5 were
obtained from the Centers for Disease Control (CDC) top 10 cancers of the overall
population for all races and genders in 2004 (Centers for Disease Control, 2007). No
subjects were located who had non-Hodgkin’s lymphoma but the other nine are
represented in the sample.
Second, each medical record was retrieved to determine a positive diagnosis of
Alzheimer’s disease, Lewy body dementia, vascular dementia, or mixed. Third, a CPS
score was calculated from their admission MDS. The CPS was calculated from the first
MDS because CPS scores may decline over time but were not likely to improve. The CPS
is calculated using a specific algorithm and scoring grid using specific MDS items.
Fourth, a DBS score was calculated from the most recent MDS before death realizing the
most recent MDS may have been in the previous 90 days. Lastly, a diagnosis of
malignant cancer and cause of death were confirmed in the medical record. This
methodology was thought to be the best way to capture active cancer pain among
individuals with dementia in a retrospective study.
Exclusion criteria were inability to determine the cause of death, and incomplete
or missing medical records. A total of 55 subjects meeting eligibility were located and
met inclusion criteria.
Pain Medication Administration
A Medical Chart Review Form (MCRF) was created for data collection
(Appendix C). The primary diagnosis was noted. Opioid containing medications were
documented, both scheduled and PRN doses and amounts were recorded over the last 14
days of life. Non-analgesic medications (potentiators) were documented and counted over
the last 14 days of life. The dose amount for narcotic medications was entered into the
MCRF form. Opioids were converted to equivalent dose units (EDU’s) for analysis using
the formula specified by the Equianalgesic Opioid Conversion rations for Patients
Previously Receiving Other Opioids (Arkansas Medicaid) on-line calculator (Arkansas
Medicaid, 2007). This calculator provides an EDU conversion factor for converting
narcotic dosages to EDU’s. For example, a resident received 30 total mg of Morphine, 40
mg of Hydrocodone, and 125 mcg of Fentanyl over the last two weeks of life. Each of
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these has an EDU equivalency. Thirty mg of Morphine equals 1.13 EDU’s, 40 mg of
hydrocodone equals 1.33 EDU’s , and 125 mcg of Fentanyl equals 15.0 EDU’s for a
total of 17.43 EDU’s during the last two weeks of life.
Demographics/Sample Characteristics
Demographic information included age, gender, type of cancer, facility, and
ethnicity (African-American, Caucasian). The hospice group was compared to the nonhospice group for equivalency using the Spearman’s Rank Correlation procedure and the
Mann Whitney U statistic.
The primary aims of this study were (1) to determine the differences in
administered pain medications for cognitively impaired residents who died from cancer
while receiving hospice services as compared with those not receiving hospice services
and (2) to determine if discomfort related pain behaviors among nursing home residents
with cancer and dementia decrease with increasing cognitive impairment.
Specific Aim One
Specific Aim One was to determine the differences in administered pain
medications for cognitively impaired residents who died from cancer while receiving
hospice services as compared with those not receiving hospice services. The following
eight hypotheses were associated with this aim.


Hypothesis 1. Residents who received hospice services would receive more
scheduled narcotic analgesic than residents who did not receive hospice
services.



Hypothesis 2. Residents who received hospice services would receive greater
total equivalent dose units (EDU’s) of narcotic analgesic than residents who
did not receive hospice services.



Hypothesis 3. Residents who received hospice services would receive greater
total dose number of non-narcotic analgesics (TDNN) than residents who did
not receive hospice services.



Hypothesis 4. Residents who received hospice services would receive more
PRN narcotic analgesic than residents who did not receive hospice services.



Hypothesis 5. Residents who received hospice services would receive more
scheduled non-narcotic analgesic than residents who did not receive hospice
services.
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Hypothesis 6. Residents who received hospice services would receive more
PRN non-narcotic analgesic than residents who did not receive hospice
services.



Hypothesis 7. Residents who received hospice services would have different
cognitive performance scores (CPS) than residents who did not receive
hospice services.



Hypothesis 8. Residents who received hospice services would receive greater
total dose numbers of drug potentiators (TDNP) than would residents who did
not receive hospice services.

Specific Aim Two
Specific Aim Two was to determine if discomfort related pain behaviors among
nursing home residents with cancer and dementia decrease with increasing cognitive
impairment. The following hypothesis is associated with this aim.
Hypothesis 9. Discomfort related pain behaviors among all residents will be
decreased with increasing cognitive impairment.
Testing the Hypotheses
In order to test the hypotheses, data were collected in the following manner:


All scheduled opioids and dose given were entered into the MCRF, if no
opioid was administered then a “0” was entered for that day.



All PRN opioids and dose given were entered into the data collection, if no
PRN opioid was administered then a “0” was entered for that day.



All scheduled non-narcotic analgesics types and dose given were entered into
the MCRF, if no non-narcotic analgesic was administered then a “0” was
entered for that day.



All PRN non-narcotic analgesic types and dose given were entered into the
MCRF; if no non-narcotic analgesic was administered then a “0” was entered
for that day.



All scheduled potentiators, types and dose given were entered into the MCRF,
if none were administered then a “0” was entered for that day.



All PRN potentiators, types and dose given were entered into the MCRF; if
none were administered then a “0” was entered into the form.
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CPS and DBS scores were calculated on each subject using the established
scoring grid for each instrument.

Mann Whitney U procedures were conducted on Hospice / Non Hospice and
continuous variables. Bivariate correlations were conducted and reported on hospice
enrollment and DBS scores. The Kruskal-Wallis procedure was conducted to answer the
final hypothesis. Alpha was set at 0.05. Beta was set at 0.20 (power of 80).
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CHAPTER 5. RESULTS
SAMPLE CHARACTERISTICS AND DEMOGRAPHIC DATA
Sociodemographic characteristics are located in Table 5-1. Forty-five percent
were male, 29% were African American, and 45% were enrolled in hospice. The mean
age of the sample was 86 (SD 7.84). Hospice enrollees are further described in Table 5-2.
Frequency and percentages of cancer types are listed in Table 5-3. Greater than 50% of
decedents had either colon/rectal or breast cancer.
Table 5-4 shows the results of hospice enrollment correlated with categorical
demographic and pain variables. Gender and race were included in the table for
completeness.
Table 5-5 shows the results of The Mann Whitney U Statistic between hospice
enrollment and continuous study variables. Age was included in the analysis for
completeness.
Hypothesis 1 was, “Residents who received hospice services would receive more
scheduled narcotic analgesic than residents who did not receive hospice services.” This
hypothesis was tested using The Spearman’s correlation procedure (Table 5-4) and an
Odds Ratio. This hypothesis was accepted. There is a significantly greater likelihood of
being prescribed a scheduled narcotic analgesic (OR 5.5; 95% CI 1.8 – 18.8) when
enrolled in hospice.
Hypothesis 2 was, “Residents who received hospice services will have different
pain management measured by greater total EDU’s during the last two weeks of life?
This hypothesis was tested using the Mann Whitney U statistic. The results are found in
Table 5 with descriptive statistics in Table 5-6. This hypothesis was accepted. Total
EDU’s were significantly greater among hospice enrollees (U 226.5, p <.05).
Hypothesis 3 was, “Residents who received hospice services will have different
pain management evidenced through receiving more TDNN during the last two weeks of
life?” This hypothesis was tested using the Mann Whitney U statistic (Table 5-5). This
hypothesis was rejected.
Hypothesis 4 was, “Residents who received hospice services will have different
pain management evidenced through being prescribed more of PRN narcotics?” This
hypothesis was tested using the Spearman’s correlation procedure (Table 5-4) and an
Odds Ratio. This hypothesis was accepted. There is a significantly greater likelihood of
being prescribed a PRN narcotic analgesic (OR 3.6; 95% CI 1.2-11.3) when enrolled in
hospice. However, individuals with higher cognitive levels were more likely (OR 3.67;
95% CI 1.19-11.26) to be prescribed a PRN narcotic. Lower cognitive levels were
defined as individuals with a CPS score of 4, 5, or 6 compared to higher cognitive levels
with a CPS score of 1, 2, and 3.

39

Table 5-1 Sociodemographics of Study Sample (N = 55)
Characteristic
n (%)
Gender
Male
25 (45)
Female
30 (54)
Race / Ethnicity
White
39 (71)
Black
16 (29)
Mean Age (Standard Deviation): Hospice patients, 86 (8.81); Non-hospice patients 88
(6.71)

Table 5-2 Characteristics of Hospice Decedents (N = 25)
Characteristic
n (%)
Hospice patients
25 (45)
Gender
Male hospice patients
11 (20)
Female hospice patients
14 (25)
Race / Ethnicity
White hospice patients
16 (29)
Black hospice patients
6 (11)
N = total number of hospice decedents; n = number in each characteristic subgroup

Table 5-3 Frequency and Percentage of Cancer Types (N = 55)
Cancer Type
n (%)
Colon / Rectal
15 (27.3)
Female breast
14 (25.5)
Prostate
9 (16.4)
Lung/Bronchiole
6 (10.9)
Uterine
3 (5.5)
Melanoma of skin
2 (3.6)
Ovarian
2 (3.6)
Kidney/Renal
2 (3.6)
Bladder
1 (1.8)
N = total number of hospice decedents; n = number in each characteristic subgroup
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Table 5-4 Correlations with Hospice Enrollment

Gender
-.027
.423

Race
-.102
.229

Spearman’s - rho
Sig (1-tailed)
* p < .01; †p < .05
PRN = as the situation demands

Scheduled
Narcotics
.393
.001*

PRN
Narcotics
.312
.010†

Scheduled
Nonnarcotics
.257
.137

PRN
Nonnarcotics
.137
.160

CPS‡
183.5
-3.122
.0011

EDU§
226.5
-2.533

Table 5-5 Hospice Enrollment and Continuous Study Variables
Mann Whitney U

Age
321.5
-.671
.251

TDNN*
339.0
-.437
.331

TDNP†
292.5
-1.217
.112

Z
Asymp. Sig (1-tailed)
.0051
1
p < .01
TDNN = total dose number of narcotics; TDNP = total dose number of potentiators;
CPS = cognitive performance scale; EDU = Equianalgesic dose units (of opioid)
*TDNN were calculated by counting all dose number of narcotic during the last 2 weeks
of life.
†TDNP were calculated by counting all dose number of potentiators; i.e.,
benzodiazipines, sedatives, hypnotics, during the last 2 weeks of life.
‡CPS scores were calculated from the admission Minimum Data Set using the
instrument algorithm.
§EDU’s were calculated over the last 2 weeks of life and placed directly into the on-line
calculator and converted to EDU amounts.

Table 5-6 Descriptive Sample Statistic of Hospice Enrollment and Mean Rank EDU
Hospice
n
Mean Rank EDUs
Sum of Ranks
Yes
25
33.94
848.50
No
30
23.051
691.50
n = number in each group; EDU = Equianalgesic dose units (of opioid)
1
p <.01 (1 tailed)
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Hypothesis 5 was, “Residents who received hospice services will have different
pain management evidenced by being prescribed more scheduled non-narcotic
analgesic?” This hypothesis was tested using The Mann Whitney U statistic (Table 5-5).
This hypothesis was rejected.
Hypothesis 6 was, “Residents who received hospice services will have different
pain management evidenced by being prescribed more an as needed (PRN) non-narcotic
analgesic?” This hypothesis was tested using The Mann Whitney U statistic (Table 5-5).
This hypothesis was rejected.
Hypothesis 7 was, “There are no differences between cognitive abilities between
residents who received hospice services and those who did not. This hypothesis was
tested using The Mann-Whitney U Statistic (Table 5-5). This hypothesis was rejected.
Descriptive statistics for this hypothesis are found in Table 6. Hospice enrollment
decreased as cognitive impairment increased (U 220.0, p < .01) with no individuals with
a CPS score of 6 (very severe impairment) enrolled in hospice. Descriptive statistics for
this hypothesis are found in Table 5-7.
Hypothesis 8 was, “Residents who received hospice services will have different
pain management evidenced by receiving more TDNP during the last two weeks of life?”
This hypothesis was tested using the Mann Whitney U Statistic (Table 5-5). This
hypothesis was rejected.
Hypothesis 9 was, “Discomfort related pain behaviors among all residents will be
decreased with increasing cognitive impairment.” This hypothesis was accepted.
Decedents with lower cognitive levels were more likely (OR 4.9; 95% CI 1.6-15.6) to
have a DBS score of zero. Lower cognitive levels were defined as individuals with a CPS
score of 4, 5, or 6 compared to higher cognitive levels with a CPS score of 1, 2, and 3.
Descriptive statistics for this hypothesis are found in Table 5-8.
An expert in pain, Perry Fine (personal communication, September, 21, 2009)
was asked to rate the cancer types as those likely to be painful to further explore the
phenomenon that no person with very severe cognitive impairment was enrolled in
hospice and that 40% of the subjects did not receive any narcotic analgesic at the end of
life and of these 31% were not enrolled in hospice while 9% were This resulted in a
dichotomous variable of cancer with “predictably painful” tumors that metastasize to the
bone (breast, lung, prostate, and renal) and those that do not (colon/rectal, bladder,
melanoma of the skin, ovarian, and uterine). Using Crosstabs in SPSS 16.0, this analysis
resulted in 9 individuals with predictably painful metastatic cancer who were very
severely cognitively impaired receiving no narcotic analgesic during the last two weeks
of life. Of note is that 29 of the 42 subjects (70%) who did not receive any narcotic
analgesic at the end of life had predictably painful metastatic cancer.
In summary, this study enrolled approximately 50% of each gender. One out of
every three individuals was African American and the average age was 87. Nearly half of
the individuals were enrolled in hospice and 50% of all subjects had breast or colon/rectal
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Table 5-7 Descriptive Sample Statistics of CPS Groups
CPS* score
N (hospice = n)
Mean EDU’s (SD)
1
7(4)
10.13 (11.14)
2
7(5)
21.83 (12.40)
3
11(8)
12.08 (12.40)
4
10(2)
10.77 (17.05)
5
8(5)
2.36 (6.13)
6
12(0)†
4.0 (7.45)
N = total number in each CPS subgroup, n = total number of hospice enrollees in each
subgroup
*CPS is scored from 1 = borderline cognitively intact to 6 = very severely cognitively
impaired.
† No individual with a CPS score of 6 was enrolled in hospice.

Table 5-8 CPS and DBS Group Comparisons
CPS
Mean DBS (SD)
1 (n = 7)
4.43(5.02)
2 (n = 7)
4.43(7.34)
3 (n = 11)
9.09 (7.46)
4 (n = 10)
7.70 (16.31)
5 (n = 8)
6.12 (11.52)
6 (n = 12)
1.92 (3.59)*
N = total number in each CPS group, SD = standard deviation
*Decedents with lower cognitive levels (4,5,6 vs. 1,2,3) were more likely [OR 4.9; 95%
CI 1.6-15.6] to have a DBS score of zero.
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cancer. The group sizes and data distribution were appropriate for nonparametric
procedures. The Spearman’s correlations and Odds ratios showed strong correlations
between hospice enrollees and being prescribed a scheduled narcotic and higher cognitive
levels and being prescribed a PRN narcotic. The Mann-Whitney U Statistic showed a
significant relationship between hospice enrollees, CPS score and total EDU’s indicating
that as cognitive impairment increases both hospice enrollment and total dose of opioid
analgesic decrease. No individual with very severe cognitive impairment was enrolled in
hospice services.
DISCUSSION
This study adds to and extends the current literature on pain management in the
nursing home. This study shows that untreated pain continues to be a serious problem
among nursing home residents with dementia. The literature is extended by showing that
nearly half of the subjects enrolled received no narcotic pain medication in the presence
of likely painful bone metastasis.
These findings also suggest that very severely cognitively impaired individuals
are not enrolled in hospice. None of the subjects with a CPS score of 6 were enrolled in
hospice. The relationship between hospice enrollment and CPS scores is telling. CPS
scores of 4, 5, and 6 have been shown to correlate with an MMSE score of < 10 and CPS
scores of 5 and 6 correlate with an MMSE score of < 5 (Hartmaier, et al., 1995; Morris, et
al., 1994) (Morris, Fries, Mehr, et al 1994; Hartmaier, Sloane, Guess, Koch, Mitchell,
Phillips, 1995) (Hartmaier, et al., 1995; Morris, et al., 1994). This suggests that the most
severely cognitively impaired are not being enrolled in hospice and that current methods
used to determine hospice enrollment among persons with malignant cancer and very
severe cognitive impairment do not work among nursing homes in western Tennessee. A
secondary reason for decreased hospice enrollment appears to be blunted pain related
behaviors. Individuals with CPS scores of 6 had the lowest DBS scores and this study
showed that DBS scores significantly decrease with increasing cognitive impairment.
Hospice enrollment might have increased the use of narcotic analgesia at the end of live
for these residents.
Nursing home residents enrolled in hospice were more likely to be prescribed a
narcotic and thus received larger quantity of narcotic analgesic during the last two weeks
of life. Introducing this paradigm into practice among nurse practitioners and physicians
who provide primary care could help reduce the amount of untreated pain in the nursing
home. This means that prescribing scheduled medications (narcotic or non-narcotic) for
various painful co-morbidities appears to be one way to reduce the possibility of being
untreated for pain. Among the severely cognitively impaired whose pain behaviors
become blunted, scheduled medications appear to be the best way to manage their pain.
Male and female participants were nearly equally represented in the study. Also
the ratio of White to Black enrollees was similar to the United States national average
with Black enrollees representing nearly 30% of this sample. Hospice enrollees were
slightly younger than non-hospice enrollees. However, bivariate analysis of nursing home
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characteristics showed that race was significantly correlated with facility (-.301, p = .025)
and that hospice was significantly correlated with facility (.337, p = .012). These findings
suggest that educational efforts to decrease administrative bias that may prohibit hospice
enrollment may not be working in Western Tennessee. Methods to enroll hospice patients
based on behavioral cues apparently do not work in the very severely cognitively
impaired.
Pain related discomfort behaviors were found to significantly decrease as
cognitive impairment increases. Bivariate analysis of discomfort behaviors showed that
race was correlated with DBS scores. Black Americans had significantly higher DBS
scores. However, as previously mentioned, this difference could be attributed to facility
bias or it may be contributed to the actual genetic, socio-cultural, or ethnic differences.
Another reason for this finding could be rater bias when filling out the MDS data
instrument. Further analysis of this finding showed that the mean total EDU’s were
nearly identical between Black and White residents. This finding has important
implications for pain behavior instrument development. Current instruments rarely, if at
all, make cultural, ethnic, or racial adjustments. Do Black individuals demonstrate
significantly more pain related behaviors that White individuals? Did Black and White
older adults in this study receive identical pain relief or were older Black adults
undertreated for pain?
A second significant correlation with DBS scores was cancer type. The four
highest DBS scores in the study were associated with prostate and breast cancer. These
cancers were identified to have predictably painful metastasis to the bone.
RECOMMENDATIONS
This study demonstrated that 40% of individuals with malignant cancer and
dementia were under medicated at the end-of life. Individuals with very severe cognitive
impairment are more likely to be undertreated for pain and not enrolled in hospice
services.
Currently there is no valid and reliable way to assess pain among persons with
very severe cognitive impairment. This study further demonstrated that total amount of
pain medication decreased as cognitive impairment increased. This means that self-report
remains the most valid assessment tool nurses use and when self-report and behaviors
becomes blunted nursing home residents with malignant cancer and dementia are
undertreated for pain. The author recommends that new methods be developed for
assessment of pain among individuals with very severe dementia.
FUTURE RESEARCH
Future studies using individuals with cognitive impairments will require more
research to discern if the pain pathways are intact. Pain consists of emotional and sensory
dimensions. Determining how pain affects persons who have the ability to communicate
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is well established in the literature – it is whatever the person says it is. However, as the
individual looses the ability to communicate assessment has been difficult and current
models rely on behavioral assessment and this will not work in the severely cognitively
impaired
Findings from this dissertation will provide direction for future research and the
next step is to determine the feasibility of using functional magnetic resonance imaging
(fMRI) to elucidate the pain pathways among persons with very severe Dementia of the
Alzheimer’s Type (DAT). Current literature suggests that individuals with DAT have
pain, but may not be able to express it. Researchers, using fMRI among cognitively intact
individuals have been able to discern between lateral and medial pain pathways
demonstrating sensory and emotional pain perception. This means that very severely
cognitively impaired older adults (CIOA) may be able to feel the pain but be unable to
verbalize or express it through physical behaviors. We must discern if the pain pathways
are intact among the very severely cognitively impaired, and if they are, we must change
the way we currently manage their pain and provide nursing care.
A second area of future research is to determine how the decision is made to
enroll in hospice. Methods exist to help clinicians determine eligibility for hospice
enrollment among persons with dementia, however findings from this study show that
people with severe dementia are not being enrolled. More research is needed to better
understand just why this is occurring.
POLICY IMPLICATIONS
Medicaid is the major payer for long term care and Medicare is the major payer
for hospice services in the nursing home. Investigators have explained how hospice
enrollment can save millions of dollars to the Medicare system, yet enrollment continues
to be a problem. Reimbursement for services, ethical incentives for enrollment, and equal
reimbursement to nursing homes for hospice are policies that must be implemented in
order to increase enrollment.
Individuals with dementia and painful co-morbidities should be given pain
medications until the time that scientists discern if the pain pathways in dementia are or
are not intact. A policy change under Medicare would be required to effectively regulate
pain management in persons who cannot behave or speak. This means that institutions
and care providers would not be federally reimbursed unless these individuals receive
some type of documented pain medication administration.
New quality measures / indicators in the nursing home or hospital should include
pain medication administration among residents / patients with dementia. For example,
admission protocols could be used that provide an easy algorithm for providers to follow
when an individual is admitted with dementia. Providing choices of scheduled nonnarcotic and narcotic medications with a PRN option then becomes the standard of care
for individuals who cannot speak or behave normally in pain. A second quality measure
could be testing the efficacy of the pain medication interventions. This means that
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individuals with dementia could have their urine and or hair randomly tested to determine
if the prescribed medications are present. This intervention could be part of the state or
federal survey and if medications are not present a system of accountability can begin.
Currently, there is no program in place to administer or monitor the efficacy of
medication interventions among individuals with severe dementia.
MOVING FINDINGS INTO PRACTICE
Moving these dissertation findings into practice will require additional research
on the physiology of dementia and pain in persons with severe dementia. A proposed
next study will use fMRI to elucidate the pain pathways in persons with severe dementia.
This technology will hopefully provide evidence that one of not all of the pain pathways
is intact. This science can then be used to design intervention and outcome studies for the
very severely cognitively impaired.
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APPENDIX C. MEDICAL CHART REVIEW FORM
Subject ID _____
LTCF ___________
Date ___________
Recorder ______
Pain Assessment and Management Form (PAM)
Dementia Diagnoses (from the medical record) ICD9 codes
______________________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________
Diagnosis of malignant cancer confirmed in the medical record
_____
Cause of death related to cancer confirmed in the medical record _____
Hospice services ❏yes
❏no
Doses over Scheduled PRN
OPIOID ANALGESICS
Dose Route 14 days
Doses
Doses
Morphine Sulfate
Controlled Released Morphine
(MS Contin, Roxanol SR,
Avinza)
Hydromorphome (Dilaudid)
Oxymorphone (Numorphan)
Levorphanol (Levo-Dromoran)
Codeine
Oxycodone (Roxicet, Percocet,
Percodan, Tylox)
Hydrocodone (Vicodin, Lortab)
Propoxyphene (Darvocet,
Darvon, Wygesic)
Meperidine (Demerol)
Fentanyl (Duragesic)
Pentazine (Talwin)
Nalbuphine (Nubain)
Buprenorphine (Buprenex)
Other
Acetaminophen
Ibuprofen
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POTENTIATORS

Dose Route Total dose amount
over last 14 days
of life
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Scheduled PRN doses
doses
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